Embedded and impacted teeth

K11_EMBIMPACT_TEETH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K01 Hospital discharge: ICD-10 — K01 Cause of death: ICD-10 — K01 3 out of 7 registries used, show all original rules.	15053
4. Check minimum number of events None	15053
5. Include endpoints None	15053
6. Filter based on genotype QC (FinnGen only)	14356

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF10

NAME	K11_EMBIMPACT_TEETH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	K01
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K01
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K01
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Embedded and impacted teeth based on the number of shared cases.

Similar with more cases:

Diseases of oral cavity, salivary glands and jaws

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	147981	83150	64212
Only index persons	142225	80503	61722
Unadjusted period prevalence (%)
Whole population	2.12	2.38	1.79
Only index persons	2.70	2.96	2.36
Median age at first event (years)
Whole population	23.84	23.95	23.66
Only index persons	24.07	24.17	23.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14356	9978	4378
Unadjusted period prevalence (%)	3.07	3.54	2.01
Median age at first event (years)	27.46	26.64	29.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14768: Matched controls
121841

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

EBA10

NOMESCO Finland

Operative extraction of tooth

10.5

307.7

8910

15431

SAA03

NOMESCO Finland

Extended examination of mouth

2.2

307.7

7956

42843

WZC00

NOMESCO Finland

Treatment plan or consultation

2.5

307.7

6736

31035

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

+∞

307.7

338

EBA00

NOMESCO Finland

Extraction of tooth

2.5

307.7

7600

36202

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.7

307.7

6748

28705

K00.7

ICD-10 Finland

Teething syndrome

3.1

307.7

1682

4867

WX110

NOMESCO Finland

Infiltration anesthesia

2.5

307.7

12039

78288

WZA90

NOMESCO Finland

Other medical or dental certificate

2.4

307.7

5043

21410

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

3.9

307.7

1683

3852

K05.32

ICD-10 Finland

Periodontitis NOS

4.8

307.7

5093

12084

K01.0

ICD-10 Finland

Embedded teeth

+∞

307.7

4313

K01.1

ICD-10 Finland

Impacted teeth

+∞

307.7

1541

K01

ICD-10 Finland

Embedded and impacted teeth

+∞

307.7

1127

K01.17

ICD-10 Finland

Retained molar with obstruction in the lower jaw

+∞

307.7

6173

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.3

307.7

9174

40523

WX290

NOMESCO Finland

Other blockage of nerve

2.8

307.7

10440

56337

ECA00

NOMESCO Finland

Surgical exposure of tooth

19.1

307.7

317

140

SAA02

NOMESCO Finland

Basic examination of mouth

2.6

307.7

12524

82798

K01.16

ICD-10 Finland

Retained molar with obstruction in the upper jaw

+∞

307.7

2711

SAA01

NOMESCO Finland

Simple examination of mouth

2.7

307.7

12552

82404

EBA12

NOMESCO Finland

Demanding operative extraction of tooth

8.6

307.7

2454

2756

K05.22

ICD-10 Finland

Acute pericoronitis

2.4

277.7

2198

8125

WZA00

NOMESCO Finland

Concise certificate

2.9

271.1

1477

4520

KAY60, ,

NOMESCO Finland

3.7

243.5

872

2057

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.8

230.8

10156

66676

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

+∞

226.8

234

K09.03

ICD-10 Finland

Cyst eruption

16.3

221.4

212

109

D82

ICPC

Teeth/gum disease

1.7

219.3

6884

40769

Z01.2

ICD-10 Finland

Dental examination

1.7

207.1

7916

49197

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

2.0

185.7

2623

12061

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

4.6

170.6

441

811

K10.3

ICD-10 Finland

Alveolitis of jaws

2.6

169.6

1101

3662

K02.1

ICD-10 Finland

Caries of dentine

1.7

164.0

10057

68620

SJD00

NOMESCO Finland

Removal and/or reactivation of orthodontic arch wire

2.7

161.2

988

3190

KAY20, ,

NOMESCO Finland

2.7

161.0

988

3192

EFA50

NOMESCO Finland

Excision of cyst of jaws

7.5

159.8

251

281

SAA04

NOMESCO Finland

Special examination of mouth

2.4

158.1

1169

4134

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

5.6

155.9

324

490

SBB10

NOMESCO Finland

Dental impressions

2.1

154.0

1779

7570

D19

ICPC

Teeth/gum symptom/complaint

1.6

152.6

4778

27518

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

152.6

788

2321

SJD10

NOMESCO Finland

Placement of orthodontic arch wire

2.6

150.4

978

3250

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

4.4

144.0

386

731

SCA01

NOMESCO Finland

Preventive oral health care, short

1.6

141.5

6036

37252

K03.64

ICD-10 Finland

Dental calculus supragingival

1.6

138.9

5827

35779

SXC05

NOMESCO Finland

Other oral or dental procedure

2.1

137.4

1502

6245

KAY40, ,

NOMESCO Finland

2.2

133.1

1308

5214

K01.10

ICD-10 Finland

Retained front tooth with obstruction in the upper jaw

+∞

130.7

135

WZB00, ,

SPAT

1.8

129.7

2407

11943

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.3

127.3

1050

3888

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.6

127.0

4990

30022

SDA03

NOMESCO Finland

Periodontal treatment

1.5

126.8

6006

37652

K07.38

ICD-10 Finland

Other anomaly in the position of the teeth

2.9

124.0

650

1927

SFA10

NOMESCO Finland

One-surface restoration

1.5

120.0

8763

59892

SJD20

NOMESCO Finland

Placement of modified orthodontic arch wire

2.6

119.1

733

2365

SJC50

NOMESCO Finland

Removal of fixed orthodontic appliance with at least 7 brackets

2.5

119.0

839

2892

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.6

116.1

4260

25118

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

2.5

114.7

795

2717

K02.0

ICD-10 Finland

Caries limited to enamel

1.6

113.9

4029

23541

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

112.8

1539

6903

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

109.5

4869

29854

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

109.4

7043

46547

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.0

106.7

1288

5532

K07.13

ICD-10 Finland

Retrognaty, mandibular

3.4

104.2

409

1020

SJX10

NOMESCO Finland

Orthodontic treatment/control appointment, short

2.0

104.0

1277

5515

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

103.3

10739

77605

SJC10

NOMESCO Finland

Orthodontic band in one tooth

2.6

102.5

628

2019

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

101.5

5281

33303

EMAK, ,

NOMESCO Finland

2.5

99.4

670

2257

EDC10

NOMESCO Finland

Sagittal osteotomy of ramus of mandible

5.0

97.2

225

376

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.3

96.7

802

2969

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

2.3

93.2

798

2994

SJD40

NOMESCO Finland

Placement of prefabricated palatal or lingual arch

2.3

90.6

757

2810

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

2.5

88.6

616

2105

-1, ,

NOMESCO Finland

1.4

85.4

5877

38690

K01.14

ICD-10 Finland

Retained premolar with obstruction in the upper jaw

+∞

85.1

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

2.7

84.9

498

1565

ECB00

NOMESCO Finland

Suture of gingiva

2.7

82.7

496

1576

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

81.7

7629

52794

W11

ICPC

Contraception oral

1.5

80.3

3401

20379

SFA20

NOMESCO Finland

Two-surface restoration

1.4

80.1

8589

60750

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

2.1

79.5

788

3134

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

76.9

1996

10713

SPAT1308

SPAT

Sexual health counselling

1.4

76.1

3977

24780

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

2.5

75.0

490

1625

SJD30

NOMESCO Finland

Demanding placement of orthodontic arch wire

2.5

74.7

499

1672

K01.15

ICD-10 Finland

Retained premolar with obstruction in the lower jaw

+∞

73.5

K01.18

ICD-10 Finland

Retained excess tooth with obstruction

+∞

69.6

-2, ,

ICD-10 Finland

2.1

68.1

669

2649

OAB42, ,

SPAT

1.6

67.1

1719

9174

ZYC02, ,

SPAT

1.8

65.4

1074

5075

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.1

64.0

672

2729

EBA12, ,

SPAT

6.6

63.8

111

140

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

63.5

1292

6490

SJX20

NOMESCO Finland

Orthodontic treatment/control appointment

2.0

60.8

678

2815

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

60.1

1216

6096

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

59.7

13050

101226

SJC40

NOMESCO Finland

Removal of fixed orthodontic appliance with at most 6 brackets

2.0

59.3

654

2705

KMAK, ,

NOMESCO Finland

1.3

58.6

7461

52985

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

58.1

2586

15510

OIKK, ,

NOMESCO Finland

1.9

57.9

826

3732

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

1.9

57.3

770

3411

SJC00

NOMESCO Finland

Bondable bracket or other fixed attachement

5.8

56.9

112

161

EBA10, ,

SPAT

3.4

56.6

221

550

SCA02

NOMESCO Finland

Preventive oral health care

1.5

56.4

2209

12916

N02BE01

ATC

paracetamol; systemic, rectal

1.4

55.9

11403

86487

K01.13

ICD-10 Finland

Retained canine with obstruction in the lower jaw

+∞

55.1

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

2.0

53.5

594

2462

VALMI, ,

NOMESCO Finland

1.3

52.5

4126

27185

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

6.2

50.8

124

127

Kela drug reimbursment

Transplant complication

3.2

50.7

218

576

WZC00, ,

SPAT

1.5

50.7

1555

8620

SPAT1363

SPAT

Health check-up performed during first study year in students of upper secondary schools, vocational schools etc.

1.4

50.6

2595

15928

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.4

50.1

2213

13213

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

49.7

2688

16645

P01

ICPC

Feeling anxious/nervous/tense

1.4

49.6

3145

20004

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

48.6

545

2267

OAB39, ,

SPAT

1.5

48.2

1492

8281

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

47.5

3214

20629

Z54.0

ICD-10 Finland

Convalescence following surgery

2.7

47.5

265

812

SPAT1312

SPAT

General health counselling

1.3

47.3

5004

34283

K07.60

ICD-10 Finland

Snapping jaw

1.7

46.8

895

4410

K07.23

ICD-10 Finland

Deep bite

2.0

44.9

549

2354

OAB44, ,

SPAT

1.5

44.8

1526

8639

SDA05

NOMESCO Finland

Very demanding periodontal treatment

1.6

43.2

1004

5206

SAB03

NOMESCO Finland

Oral health check

1.6

41.4

1159

6280

A97

ICPC

No disease

1.4

40.8

2360

14728

J01CA04

ATC

amoxicillin; systemic

1.4

40.4

12484

97333

OAB36, ,

SPAT

1.9

40.4

573

2582

EEC05

NOMESCO Finland

Le Fort I osteotomy

4.1

40.0

117

238

L04AA06

ATC

mycophenolic acid; systemic

2.7

39.8

231

723

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

2.2

39.3

330

1226

WZA10, ,

SPAT

2.0

39.3

433

1790

K07.39

ICD-10 Finland

Anomaly in the position of the teeth UNS

2.7

38.7

214

653

ZYC01, ,

SPAT

1.4

38.1

1741

10421

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.4

37.9

2592

16586

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

2.1

37.8

369

1457

K07.24

ICD-10 Finland

Open bite

2.3

37.2

298

1086

R21

ICPC

Throat symptom/complaint

1.3

36.7

4518

31297

SAC01

NOMESCO Finland

Separate planning of oral and dental treatment, standard

1.9

36.3

476

2091

L04AA01

ATC

[U] ciclosporin

3.3

35.9

141

353

Z94.0

ICD-10 Finland

Kidney transplant status

3.2

35.9

152

399

OIKH, ,

NOMESCO Finland

1.8

35.8

532

2433

A05

ICPC

Feeling ill

1.5

35.6

1429

8342

K00.69

ICD-10 Finland

Disorders in the tooth eruption UNS

3.0

35.3

162

446

K03.30

ICD-10 Finland

Internal granuloma of pulp

4.5

35.3

171

SJB60

NOMESCO Finland

Adjustment and grinding of removable appliance

1.9

35.0

448

1951

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

34.7

1587

9488

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

34.7

1100

6121

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

34.6

706

3537

SAB02

NOMESCO Finland

Oral and dental health check by dental hygienist or dental assistant

1.4

34.4

1858

11436

K07.3

ICD-10 Finland

Anomalies of tooth position

3.0

34.1

159

442

SAALT, ,

NOMESCO Finland

2.2

34.1

292

1095

SPAT1364

SPAT

Health check-up performed during second study year in students of upper secondary schools, vocational schools etc.

1.5

33.3

1221

6997

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

32.8

1216

6983

EC1VA, ,

NOMESCO Finland

2.0

32.3

368

1540

OAB38, ,

SPAT

1.7

31.8

604

2967

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

31.6

2396

15520

IHZ05, ,

SPAT

1.5

30.4

952

5279

ECB15

NOMESCO Finland

Plastic repair of oronasal or oroantral fistula

4.6

30.2

134

SXC03

NOMESCO Finland

Other oral or dental procedure

3.0

29.7

135

370

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

29.7

2069

13226

SJA04

NOMESCO Finland

Very demanding workplan for orthodontic treatment

4.8

29.3

121

SPAT1192

SPAT

Gynaecological examination

1.3

29.3

2189

14135

IHZ02, ,

SPAT

1.8

29.2

425

1931

SPAT1263

SPAT

Sampling

1.2

28.9

5643

40866

K05.33

ICD-10 Finland

Thickened dental follicle

13.8

28.9

L04AD02

ATC

tacrolimus; systemic

2.8

28.8

147

431

K08.80

ICD-10 Finland

Toothache NOS

1.4

28.6

1221

7199

ZYC05, ,

SPAT

1.6

28.5

681

3550

K01.11

ICD-10 Finland

Retained front tooth with obstruction in the lower jaw

+∞

28.0

K09.09

ICD-10 Finland

Odontogenic developmental cyst UNS

10.4

27.9

WGA11, ,

SPAT

2.1

27.7

267

1050

X02

ICPC

Menstrual pain

1.5

27.5

802

4378

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.0

27.3

315

1325

QXA70, ,

SPAT

1.9

26.9

358

1581

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

26.7

4255

30100

K05.39

ICD-10 Finland

Periodontitis UNS

2.7

26.5

143

432

SKA40, ,

NOMESCO Finland

2.0

26.5

318

1357

A04

ICPC

Weakness/tiredness general

1.3

26.5

2021

13075

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

26.1

2576

17241

SPAT1283

SPAT

Restricted health certificate

1.2

25.9

3875

27214

SJD50

NOMESCO Finland

Placement of prefabricated palatal or lingual arch, dentist-made

2.4

25.8

182

628

OIKVA, ,

NOMESCO Finland

1.9

25.7

358

1606

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

25.6

942

5396

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.4

25.6

230

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.2

25.3

105

273

SCF02

NOMESCO Finland

Preventive oral care by dental hygienist

1.6

25.1

665

3553

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

1.9

25.0

336

1490

R2130, ,

SPAT

1.8

24.4

374

1727

SPAT1193

SPAT

Pap smear

1.3

24.2

1660

10565

SPAT1325

SPAT

Vaccination

1.2

24.1

3457

24133

K07.14

ICD-10 Finland

Retrognaty, maxillary

2.9

24.1

114

321

A12AA04

ATC

calcium carbonate; oral

2.8

23.8

123

364

K00.00

ICD-10 Finland

Hypodontia

2.1

23.7

242

974

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

23.7

161

547

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

23.4

4295

30731

K05.08

ICD-10 Finland

Another acute gingivitis

1.7

23.3

467

2329

SPAT1254

SPAT

Administration of medicine

1.3

23.1

1762

11383

K05.30

ICD-10 Finland

Periodontitis complex

1.4

23.0

1052

6275

K03.66

ICD-10 Finland

Tooth plaque

1.5

22.9

897

5201

J01DA08

ATC

[U] cefaclor

1.3

22.6

2527

17133

SMAK, ,

NOMESCO Finland

3.0

22.3

105

295

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

22.0

8704

66624

IGY99, ,

SPAT

1.7

21.9

450

2260

R03CC02

ATC

salbutamol; systemic

1.3

21.8

1736

11276

A11CC03

ATC

alfacalcidol; systemic

2.2

21.6

177

654

SPAT1181

SPAT

Ultrasound examination of uterus and uterine appendages

1.6

21.4

591

3187

-1, ,

SPAT

1.5

21.2

726

4100

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

20.8

1097

6698

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

20.8

5285

38869

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

20.7

734

4175

EMB30

NOMESCO Finland

Adenotomy

1.4

20.6

872

5125

SJX00

NOMESCO Finland

Reparation of orthodontic appliance by dentist

2.4

20.5

149

523

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

2.6

20.2

121

387

S82

ICPC

Naevus/mole

1.3

19.9

1586

10292

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

19.7

1521

9827

EBB10

NOMESCO Finland

Insertion of dental implant

2.3

19.6

151

544

P03

ICPC

Feeling depressed

1.3

19.5

2045

13737

R1430, ,

SPAT

1.9

19.5

248

1081

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

19.5

491

2593

H01

ICPC

Ear pain/earache

1.3

19.3

1827

12122

S96

ICPC

Acne

1.6

19.2

413

2100

K07.20

ICD-10 Finland

Crossbite (anterior)(posterior)

2.0

19.1

206

848

EB1HA, ,

SPAT

1.9

19.0

237

1027

SPAT1366

SPAT

Health check-up performed based on health survey in students of universities, universities of applied sciences etc.

1.4

19.0

752

4369

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

18.9

147

532

K07.10

ICD-10 Finland

Asymmetry of jaw

3.1

18.8

208

WZA00, ,

SPAT

1.6

18.7

422

2171

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

18.7

4721

34614

HAHOM, ,

NOMESCO Finland

2.0

18.6

193

783

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.1

18.3

207

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

18.1

4124

29946

HMAK, ,

NOMESCO Finland

1.3

18.1

1444

9372

L17

ICPC

Foot/toe symptom/complaint

1.2

18.0

2917

20527

SPAT1310

SPAT

Counselling related to known health issue

1.2

17.9

4029

29218

K07.61

ICD-10 Finland

Cracking jaw joint

1.7

17.9

343

1692

EB4VA, ,

NOMESCO Finland

1.3

17.6

1454

9475

X23

ICPC

Fear sexually transm dis female

1.3

17.6

1440

9372

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

6.2

17.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

17.5

4783

35253

SPAT1316

SPAT

Extensive health check-up of children and adolescents

1.3

17.4

1587

10472

N01

ICPC

Headache

1.2

17.4

2313

15942

M79.1

ICD-10 Finland

Myalgia

1.3

17.4

1714

11420

SPAT1324

SPAT

Screening procedure

1.2

17.3

2025

13763

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

17.3

3308

23630

K03.00

ICD-10 Finland

Approximal wear

1.4

17.3

820

4917

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

1.7

17.3

298

1428

EB1KA

NOMESCO Finland

Partial (restricted area) panoramic tomography of teeth or jaw

2.7

17.3

287

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

17.1

903

5514

U02

ICPC

Urinary frequency/urgency

1.3

16.6

1445

9477

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

16.6

2380

16531

D01

ICPC

Abdominal pain/cramps general

1.3

16.5

1786

12027

K09.29

ICD-10 Finland

Cyst of jaw traumatic

3.9

16.4

106

L70.0

ICD-10 Finland

Acne vulgaris

1.4

16.3

840

5108

W14

ICPC

Contraception female other

1.3

16.3

1410

9243

L04AD01

ATC

ciclosporin; systemic

2.0

16.2

189

801

SJA03

NOMESCO Finland

Demanding workplan for orthodontic treatment

3.6

16.2

126

LKKIR, ,

NOMESCO Finland

6.3

16.2

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.3

16.2

1187

7611

R50.9

ICD-10 Finland

Fever, unspecified

1.3

15.9

1655

11090

SFA00

NOMESCO Finland

Small restoration

1.3

15.9

1449

9557

M01AE02

ATC

naproxen; oral, rectal

1.2

15.9

7442

57009

L16

ICPC

Ankle symptom/complaint

1.3

15.9

1411

9279

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.1

15.8

151

595

137

Kela drug reimbursment

Uraemia requiring dialysis

2.8

15.7

236

SCE00

NOMESCO Finland

Fissure sealant

1.5

15.7

564

3217

X16

ICPC

Vulval symptom/complaint

1.7

15.7

271

1301

Z01.8

ICD-10 Finland

Other specified special examinations

1.2

15.4

2125

14685

SPAT1240

SPAT

Therapeutic discussion

1.2

15.3

1949

13357

SPAT1301

SPAT

No procedures

1.2

15.2

3507

25420

R74

ICPC

Upper respiratory infection acute

1.2

15.2

5714

43028

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

15.2

1113

7137

EB1WA, ,

NOMESCO Finland

2.8

15.1

227

EB1BD

NOMESCO Finland

Extensive cone beam CT of teeth and jaws (two quarters)

4.7

15.0

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.9

15.0

197

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

14.9

3848

28147

G47.8

ICD-10 Finland

Other sleep disorders

1.7

14.9

281

1383

SAC03

NOMESCO Finland

Separate planning of oral and dental treatment, very demanding

2.4

14.9

105

365

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.6

14.8

376

1992

L70

ICD-10 Finland

Acne

1.4

14.7

582

3381

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

14.7

1857

12716

WX199

NOMESCO Finland

Other local analgesia

1.9

14.7

189

830

SJE90

NOMESCO Finland

Orthodontic finishing

2.6

14.7

264

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.2

14.6

2202

15356

LC2AE, ,

SPAT

2.0

14.5

164

689

R51.80

ICD-10 Finland

Headache

1.2

14.4

2189

15268

J01DB01

ATC

cefalexin; oral

1.2

14.4

11068

87580

EFB40

NOMESCO Finland

Removal of internal or external fixation device from facial bones

2.9

14.2

194

IDY99, ,

SPAT

2.0

14.2

146

593

EWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of teeth, jaws, mouth and pharynx

5.3

14.1

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

14.0

2387

16832

K00.6

ICD-10 Finland

Disturbances in tooth eruption

2.5

14.0

310

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

14.0

1077

6952

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

13.9

766

4708

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

2.1

13.9

130

510

SJA02

NOMESCO Finland

Workplan for orthodontic treatment

3.8

13.8

R02

ICPC

Shortness of breath/dyspnoea

1.3

13.8

1130

7354

Z10.8

ICD-10 Finland

Routine general health check-up of other defined subpopulations

1.3

13.7

1060

6843

S04

ICPC

Lump/swelling localized

1.3

13.7

1235

8131

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.3

13.7

1365

9097

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

13.7

851

5329

SPAT1216

SPAT

Assessment of functional ability

1.3

13.7

850

5323

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

13.6

314

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

13.5

2738

19599

126

Kela drug reimbursment

Chronic coagulation defects

5.1

13.5

R01AD58

ATC

fluticasone, combinations; nasal

1.2

13.5

3486

25467

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

13.4

485

2771

Z00.0

ICD-10 Finland

General medical examination

1.2

13.3

2184

15339

OIKRE, ,

NOMESCO Finland

2.2

13.3

114

432

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.5

13.3

283

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.4

13.2

751

4641

K07.04

ICD-10 Finland

Macrognathism (mandibular)(maxillary)

4.1

13.2

K03.5

ICD-10 Finland

Ankylosis of teeth

5.7

13.1

TK800

NOMESCO Finland

Hemodialysis

2.0

13.1

139

572

W12

ICPC

Contraception intrauterine

1.2

13.0

2102

14744

KAY30, ,

NOMESCO Finland

1.7

13.0

232

1127

K07.11

ICD-10 Finland

Retrognathism (mandibular)(maxillary)

2.6

12.9

252

SFA30

NOMESCO Finland

Three-surface restoration

1.2

12.8

4092

30354

N18.0

ICD-10 Finland

End-stage renal disease

2.7

12.8

206

R53

ICD-10 Finland

Malaise and fatigue

1.2

12.8

2760

19860

XLD10, ,

SPAT

1.7

12.7

224

1084

Z94.4

ICD-10 Finland

Liver transplant status

3.5

12.7

103

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.4

12.6

631

3820

XQ845

NOMESCO Finland

Dermatoscopy

2.2

12.6

106

399

SCC01

NOMESCO Finland

Fluoride application or other respective small prophylactic procedure

1.5

12.6

427

2412

B03XA01

ATC

erythropoietin; parenteral

3.1

12.5

141

WX002

NOMESCO Finland

Sedation and analgesia

1.3

12.5

1307

8758

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

12.5

1730

11950

X72

ICPC

Genital candidiasis female

1.7

12.3

231

1137

S21

ICPC

Skin texture symptom/complaint

1.2

12.2

1329

8945

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.1

12.2

135

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

12.1

1573

10791

K07.22

ICD-10 Finland

Anomalies of dental arch relationship

2.0

12.0

129

533

Z49.2

ICD-10 Finland

Other dialysis

2.7

12.0

190

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

11.9

1681

11626

SPC20

NOMESCO Finland

Implant borne crown

2.4

11.9

293

J01FA10

ATC

azithromycin; systemic

1.1

11.9

8344

65083

N94.4

ICD-10 Finland

Primary dysmenorrhoea

1.4

11.9

472

2748

EDW99

NOMESCO Finland

Other operation on mandible

5.3

11.8

Z71.8

ICD-10 Finland

Other specified counselling

1.1

11.8

4163

31064

SPAT1211

SPAT

Application of soft bandage

1.3

11.7

901

5814

L01

ICPC

Neck symptom/complaint

1.2

11.6

1770

12332

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.5

11.6

241

Z48.8

ICD-10 Finland

Other specified surgical follow-up care

2.2

11.6

364

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.4

11.6

598

3641

EDA00

NOMESCO Finland

Incision of mandibular abscess

2.8

11.5

180

TLC00, ,

SPAT

1.4

11.5

515

3061

WYA00

NOMESCO Finland

Screening and health check-up

1.8

11.5

162

734

A03

ICPC

Fever

1.2

11.5

2888

21009

B05DA

ATC

Isotonic solutions

2.7

11.5

199

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

11.5

6971

53835

R05

ICPC

Cough

1.2

11.5

2779

20162

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

11.4

1120

7448

Z00.1

ICD-10 Finland

Routine child health examination

1.3

11.4

1005

6601

SJB10

NOMESCO Finland

Fitting of removable appliance incl. patient instructions, demanding

1.7

11.3

202

982

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.2

11.2

1757

12277

G50.1

ICD-10 Finland

Atypical facial pain

1.9

11.1

142

624

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.2

11.1

2073

14719

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.3

11.0

668

4169

K00.10

ICD-10 Finland

The incisor and canine region, including the mesiodens

3.8

11.0

EBB15

NOMESCO Finland

Insertion of dental implant abutment

2.3

11.0

309

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

11.0

1915

13508

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.2

10.9

1161

7793

BE00A, ,

NOMESCO Finland

5.3

10.9

K02.3

ICD-10 Finland

Arrested dental caries

1.6

10.8

269

1422

SKA60, ,

NOMESCO Finland

1.7

10.8

189

914

R09

ICPC

Sinus symptom/complaint

1.3

10.8

1111

7429

L15

ICPC

Knee symptom/complaint

1.2

10.8

2202

15747

L03

ICPC

Low back symptom/complaint

1.2

10.7

3209

23637

A98

ICPC

Health maint/preventive medicine

1.4

10.7

14368

117192

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

1.8

10.7

169

794

L07

ICPC

Jaw symptom/complaint

1.7

10.7

210

1048

D68.0

ICD-10 Finland

Von Willebrand disease

3.1

10.7

124

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

3.3

10.7

103

K10.20

ICD-10 Finland

Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)

4.5

10.6

K00.12

ICD-10 Finland

Excess teeth in the molar region

4.5

10.6

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.3

10.6

1021

6778

EMB10

NOMESCO Finland

Tonsillectomy

1.2

10.5

1121

7524

EDC30

NOMESCO Finland

Genioplasty

5.3

10.5

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

4.6

10.5

SPAT1260

SPAT

Consultation of another employee

1.2

10.4

1780

12531

OIKAL, ,

NOMESCO Finland

1.7

10.4

194

955

EBA40

NOMESCO Finland

Extraction of apex of root of tooth

2.2

10.4

317

WX290, ,

SPAT

1.4

10.3

490

2946

Z50.1

ICD-10 Finland

Other physical therapy

1.5

10.3

311

1718

K07.1

ICD-10 Finland

Anomalies of jaw-cranial base relationship

3.2

10.2

110

OAB76, ,

SPAT

1.6

10.2

209

1054

WKPER, ,

NOMESCO Finland

1.9

10.2

132

583

H29

ICPC

Ear symptom/complaint other

1.3

10.2

943

6228

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.2

10.2

1061

7105

SPAT1284

SPAT

Extensive health certificate

1.5

10.2

361

2059

ZXA10

NOMESCO Finland

Bilateral

1.2

10.2

1334

9158

S06

ICPC

Rash localized

1.4

10.1

506

3070

R83

ICPC

Respiratory infection other

1.1

10.1

4535

34305

K03.80

ICD-10 Finland

Irradiated enamel

1.3

10.0

614

3840

L11

ICPC

Wrist symptom/complaint

1.2

10.0

1133

7658

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

10.0

728

4667

K07.27

ICD-10 Finland

Anomalies of dental arch relationship

1.8

9.9

143

655

B05DB

ATC

Hypertonic solutions

2.6

9.9

181

R07

ICPC

Sneezing/nasal congestion

1.2

9.9

1113

7518

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.2

9.9

324

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

1.7

9.8

184

908

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

1.5

9.8

287

1575

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.3

9.8

722

4633

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

9.8

2549

18569

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

9.8

1983

14167

R4135

NOMESCO Finland

Rehabilitation for hearing problems

2.7

9.8

168

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

1.8

9.8

141

646

SCB01

NOMESCO Finland

Instructions for self-performed oral hygiene, short

1.8

9.7

155

731

602

Kela drug reimbursment

Children's severe malnutrition

2.3

9.7

258

B03XA02

ATC

darbepoetin alfa; parenteral

2.0

9.6

102

422

K09.08

ICD-10 Finland

Another edontogenic developmental cyst

5.6

9.5

R01BA52

ATC

pseudoephedrine, combinations; oral

0.8

9.5

1594

15361

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

9.5

508

3113

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.4

9.5

391

2296

JJC00

NOMESCO Finland

Allogenic transplantation of liver

4.1

9.5

J01FF01

ATC

clindamycin; systemic

1.2

9.4

2464

17957

S29

ICPC

Skin symptom/complaint other

1.2

9.4

1835

13066

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

1.9

9.4

121

535

E0000UV, ,

ATC

1.1

9.4

5081

38819

LEB1H, ,

NOMESCO Finland

3.2

9.3

V03AE02

ATC

sevelamer; oral

2.9

9.3

126

OAA43, ,

SPAT

1.5

9.2

248

1337

EBW99

NOMESCO Finland

Other operation on tooth

5.4

9.2

SPAT1367

SPAT

Health check-up due to individual need in students of upper secondary schools or vocational schools

1.6

9.2

217

1136

K09.00

ICD-10 Finland

Cyst dentigerous

15.5

9.2

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

3.7

9.1

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

9.1

825

5436

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.1

9.1

3356

25035

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.5

9.1

194

N30.0

ICD-10 Finland

Acute cystitis

1.2

9.1

1706

12105

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

9.1

915

6107

L04AX01

ATC

azathioprine; systemic

1.4

9.0

429

2580

SPAT1016

SPAT

Examination of vision

1.3

9.0

629

4007

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.3

9.0

235

K07.12

ICD-10 Finland

Prognathism (mandibular)(maxillary)

3.4

8.9

K13.1

ICD-10 Finland

Cheek and lip biting

2.1

8.9

316

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

2.8

8.9

129

OAA10, ,

SPAT

1.2

8.9

961

6463

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.6

8.9

220

1165

UDC00

NOMESCO Finland

Ear microscopy

1.3

8.9

693

4485

J35.0

ICD-10 Finland

Chronic tonsillitis

1.2

8.8

952

6401

OAA11, ,

SPAT

1.2

8.8

1426

9985

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

8.7

1406

9841

K08.3

ICD-10 Finland

Retained dental root

1.4

8.7

464

2843

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

1.5

8.7

261

1442

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.3

8.7

735

4806

K03.60

ICD-10 Finland

Deposits [accretions] on teeth black

2.0

8.7

387

ECB05

NOMESCO Finland

Mucogingival remodeling

2.5

8.6

189

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

8.6

1308

9104

H66.9

ICD-10 Finland

Otitis media, unspecified

1.2

8.6

1124

7710

TK820

NOMESCO Finland

Peritoneal dialysis

2.9

8.5

114

F03

ICPC

Eye discharge

1.3

8.5

767

5052

S02.66

ICD-10 Finland

Fracture of the angulus mandipulae

4.6

8.5

EB1VA, ,

NOMESCO Finland

1.2

8.5

1231

8532

U01

ICPC

Dysuria/painful urination

1.2

8.4

900

6045

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

8.4

221

1187

D06

ICPC

Abdominal pain localized other

1.2

8.4

1049

7165

Z02.7

ICD-10 Finland

Issue of medical certificate

1.3

8.4

681

4429

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.2

8.4

1365

9564

SPAT1389

SPAT

Visit based on need for special support

1.3

8.3

635

4097

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.2

8.3

1074

7361

L02

ICPC

Back symptom/complaint

1.2

8.3

1259

8763

J01CA08

ATC

pivmecillinam; oral

1.1

8.3

4669

35685

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

8.3

103

451

Z94.1

ICD-10 Finland

Heart transplant status

3.5

8.2

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.6

8.2

149

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

8.2

1087

7465

Z99.2

ICD-10 Finland

Dependence on renal dialysis

4.0

8.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

8.2

534

3375

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.7

8.2

156

776

K00.29

ICD-10 Finland

Other or indefinite deviation in the shape or size of the teeth

4.6

8.1

N89

ICPC

Migraine

1.3

8.1

703

4609

X08

ICPC

Intermenstrual bleeding

1.5

8.1

264

1485

SPAT1044

SPAT

Tympanometry

1.5

8.1

253

1412

L20.0

ICD-10 Finland

Besnier prurigo

1.2

8.1

1284

8978

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.1

8.0

3331

25005

RETAL, ,

NOMESCO Finland

4.3

8.0

K07.26

ICD-10 Finland

Anomalies of dental arch relationship

3.2

8.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

7.9

369

2214

N76.0

ICD-10 Finland

Acute vaginitis

1.2

7.9

1171

8130

SJB30

NOMESCO Finland

Extraoral traction arrangements and operation instruction, removable appliance

1.7

7.9

127

602

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.5

7.9

162

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.2

7.9

880

5939

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.6

7.9

166

847

SPAT1241

SPAT

Extensive assessment of psychosocial situation

1.5

7.9

219

1193

SAA03, ,

SPAT

4.0

7.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

7.8

1963

14246

K03.39

ICD-10 Finland

Pathological resorption of teeth UNS

2.7

7.8

134

A07AA02

ATC

nystatin; oral

1.4

7.8

295

1708

K09.02

ICD-10 Finland

Cyst lateral periodontal

6.8

7.8

H92.0

ICD-10 Finland

Otalgia

1.3

7.8

772

5146

SJC20

NOMESCO Finland

Extraoral traction appliance arrangement incl. patient instructions

2.0

7.8

323

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.4

7.8

345

2056

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

7.8

180

941

JOUK, ,

NOMESCO Finland

2.1

7.7

301

RTGKO, ,

NOMESCO Finland

3.6

7.7

OAA53, ,

SPAT

1.6

7.7

173

897

S02.61

ICD-10 Finland

Fracture of mandible, open

3.1

7.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.1

7.7

2551

18876

Z2221

NOMESCO Finland

Medical doctor

0.9

7.7

2292

21159

K07.68

ICD-10 Finland

Other disorders of the jaw joint

1.8

7.7

104

469

F02

ICPC

Red eye

1.3

7.6

441

2739

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

2.5

7.6

165

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.2

7.6

1234

8640

XCW10

NOMESCO Finland

Assessment of vision

2.2

7.6

232

F29

ICPC

Eye symptom/complaint other

1.2

7.6

957

6543

X15

ICPC

Vaginal symptom/complaint other

1.3

7.6

660

4332

5AB14, ,

NOMESCO Finland

3.4

7.6

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

1.8

7.5

117

550

LABPK, ,

NOMESCO Finland

2.2

7.5

228

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.2

7.5

1084

7511

TLC02, ,

SPAT

1.5

7.5

232

1293

K07.4

ICD-10 Finland

Malocclusion, unspecified

1.5

7.4

204

1108

EBA99

NOMESCO Finland

Other extraction or partial excision of tooth

4.2

7.4

R07.0

ICD-10 Finland

Pain in throat

1.2

7.4

1022

7050

N17

ICPC

Vertigo/dizziness

1.2

7.4

966

6629

O70.1

ICD-10 Finland

Second degree perineal laceration during delivery

1.3

7.4

475

2997

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

1.6

7.4

171

894

A01AB10

ATC

natamycin; local oral

1.4

7.4

306

1803

Z76.2

ICD-10 Finland

Health supervision and care of other healthy infant and child

1.9

7.4

364

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

3.1

7.3

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

7.3

2217

20455

S15

ICPC

Foreign body in skin

1.3

7.3

456

2864

R11

ICD-10 Finland

Nausea and vomiting

1.2

7.3

960

6591

D09

ICPC

Nausea

1.2

7.3

824

5572

UJF32

NOMESCO Finland

Coloscopy

1.2

7.3

1563

11209

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.2

7.3

1227

8625

R06

ICPC

Nose bleed/epistaxis

1.6

7.2

153

784

SJF01

NOMESCO Finland

Assessment of need for orthodontic treatment

1.4

7.2

349

2112

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.1

7.2

2619

19492

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

7.2

1258

8874

SPAT1058

SPAT

PEF monitoring instruction

1.3

7.1

638

4206

SPAT1243

SPAT

Psychiatric/psychological examination

1.3

7.1

500

3198

R1250, ,

SPAT

1.4

7.1

252

1445

A03FA02

ATC

cisapride; oral, rectal

1.3

7.1

398

2465

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

1.3

7.0

404

2510

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

1.8

7.0

429

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.2

7.0

230

K06.00

ICD-10 Finland

Local gingivore traction

1.5

7.0

182

978

WGA10, ,

SPAT

2.2

7.0

209

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.2

7.0

818

5555

JJ5AT, ,

NOMESCO Finland

7.3

7.0

Q87.09

ICD-10 Finland

Other congenital malformations that mainly affect the appearance of the face

7.3

7.0

EGC10

NOMESCO Finland

Arthroplasty of mandibular joint without graft

4.4

7.0

K06.18

ICD-10 Finland

Another gingival hyperplasia

2.6

6.9

128

EEC02

NOMESCO Finland

Rapid expansion of maxilla

6.7

6.9

X05

ICPC

Menstruation absent/scanty

1.4

6.9

259

1498

D11

ICPC

Diarrhoea

1.2

6.9

1710

12391

ECB40

NOMESCO Finland

Surgical treatment of fracture of alveolus

2.1

6.9

231

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.3

6.9

557

3624

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.3

6.9

375

2311

T05

ICPC

Feeding problem of adult

1.6

6.9

145

742

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

1.2

6.9

1070

7469

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.2

6.9

1105

7736

X04

ICPC

Painful intercourse female

1.7

6.9

109

517

Z02.3

ICD-10 Finland

Examination for recruitment to armed forces

1.3

6.8

630

4165

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

1.9

6.8

368

D54

ICPC

Digestive, Repair/fix-suture/cast/prosth device

8.9

6.8

Z71.9

ICD-10 Finland

Counselling, unspecified

1.2

6.8

696

4656

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.4

6.8

327

1976

XPX08

NOMESCO Finland

Intraoperative flow measurement

2.8

6.8

101

P86

ICPC

Anorexia nervosa/bulimia

1.8

6.8

410

S17

ICPC

Abrasion/scratch/blister

1.4

6.8

284

1678

L12

ICPC

Hand/finger symptom/complaint

1.1

6.8

1819

13265

WX110, ,

SPAT

1.2

6.7

671

4476

Z01.9

ICD-10 Finland

Special examination, unspecified

1.3

6.7

422

2655

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.3

6.7

467

2980

H26.3

ICD-10 Finland

Drug-induced cataract

2.5

6.7

145

OAA62, ,

SPAT

1.2

6.7

1487

10688

X01

ICPC

Genital pain female

1.6

6.7

161

850

H60.8

ICD-10 Finland

Other otitis externa

1.4

6.7

277

1632

S02AA30

ATC

antiinfectives, combinations; otic

1.2

6.7

934

6452

R52.9

ICD-10 Finland

Pain, unspecified

1.2

6.7

862

5910

SPAT1057

SPAT

Peak expiratory flow measurement

1.5

6.7

177

956

Z00.3

ICD-10 Finland

Examination for adolescent development state

1.3

6.7

440

2789

Z37.0

ICD-10 Finland

Single live birth

0.8

6.6

1150

11060

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.3

6.6

584

3841

K05.0

ICD-10 Finland

Acute gingivitis

1.4

6.6

270

1587

TNX30, ,

SPAT

2.7

6.6

112

WX704

NOMESCO Finland

Intubation

1.3

6.6

643

4279

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

2.1

6.6

225

K10.21

ICD-10 Finland

Osteoradionecrosis of jaw (acute)(chronic)(suppurative)

3.8

6.6

L28

ICPC

Limited function/disability (L)

1.2

6.6

862

5920

K00.41

ICD-10 Finland

Prenatal enamel hypoplasia

3.0

6.6

ECB20

NOMESCO Finland

Oral alveoplasty

2.1

6.5

226

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

6.5

334

2040

IHA10, ,

SPAT

1.6

6.5

128

644

EDA10

NOMESCO Finland

Biopsy of mandible

3.1

6.5

S22

ICPC

Nail symptom/complaint

1.3

6.5

521

3389

H13

ICPC

Plugged feeling ear

1.2

6.5

1293

9217

WW200, ,

SPAT

1.1

6.5

1914

14045

J01EA01

ATC

trimethoprim; systemic

1.1

6.5

2369

17625

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

2.2

6.5

184

ZX108

NOMESCO Finland

Inhalation

2.2

6.4

195

XX1VW, ,

SPAT

1.9

6.4

329

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

3.3

6.4

P76

ICPC

Depressive disorder

1.2

6.4

1026

7182

F51.0

ICD-10 Finland

Nonorganic insomnia

1.1

6.4

2121

15686

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.3

6.4

385

2412

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

1.9

6.4

348

EB1S1

NOMESCO Finland

Photography of teeth

2.1

6.3

246

N25.0

ICD-10 Finland

Renal osteodystrophy

4.0

6.3

OPTG, ,

NOMESCO Finland

3.2

6.3

R05

ICD-10 Finland

Cough

1.1

6.3

1966

14484

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

6.3

284

1702

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

1.4

6.3

316

1927

-48

ICPC

Clarification/discussion RFE/demand

1.3

6.3

414

2627

G44.2

ICD-10 Finland

Tension-type headache

1.2

6.2

1530

11081

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.1

6.2

1966

14488

B07.9

ICD-10 Finland

Verruca simplex

1.3

6.2

419

2664

B02BD02

ATC

coagulation factor VIII; parenteral

9.9

6.2

F32.1

ICD-10 Finland

Moderate depressive episode

1.2

6.2

957

6673

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

1.6

6.2

138

716

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

6.2

772

7646

R01AD09

ATC

mometasone; nasal

1.1

6.2

5629

43895

QXE99, ,

SPAT

1.8

6.1

430

S03

ICPC

Warts

1.4

6.1

235

1368

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

6.1

949

6622

IBA01, ,

SPAT

1.5

6.1

184

1022

SPAT1387

SPAT

Health survey during first study year, university level

1.3

6.1

328

2019

R03CC03

ATC

terbutaline; systemic

1.3

6.1

534

3511

TKA05

NOMESCO Finland

Aspiration cytology of kidney

11.4

6.1

K02

ICD-10 Finland

Dental caries

1.2

6.1

706

4790

R08

ICPC

Nose symptom/complaint other

1.3

6.1

390

2466

5850B

ICD-9 Finland

Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]

13.8

6.0

EB1SA, ,

SPAT

1.2

6.0

645

4341

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

2.2

6.0

169

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1761482) Bacteria [#/volume] in Urine by Culture

396

1230

2.70

69.02

4.2

3.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

414

1457

2.38

55.76

1.6

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5376

37338

1.30

45.32

3.5

3.0

—

(3008037) Lactate [Moles/volume] in Venous blood

295

990

2.49

44.08

3.2

2.5

1.38

1.44

mmol/l

0.55

290

965

(3000330) Specific gravity of Urine by Test strip

680

3202

1.79

41.55

3.8

2.6

—

(3035350) Ketones [Presence] in Urine by Test strip

6619

47702

1.26

39.55

3.5

3.0

0.00

estimate

3.13

1372

10163

(3021601) Nitrite [Presence] in Urine by Test strip

6583

47695

1.25

36.38

4.9

4.2

0.00

estimate

2.33

1327

10121

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

510

2294

1.86

36.13

4.6

3.8

49.91

50.75

0.30

502

2266

(3009261) Glucose [Presence] in Urine by Test strip

6619

48047

1.25

35.72

3.6

3.0

0.00

estimate

0.10

1306

9826

(3019150) Specific gravity of Urine by Refractometry

3177

21212

1.30

33.96

3.6

3.1

1.01

1.02

kg/l

0.79

463

3118

(3026250) Tacrolimus [Mass/volume] in Blood

156

433

2.99

33.57

38.0

38.3

7.23

7.49

ug/l

0.91

142

409

(3027273) Bicarbonate [Moles/volume] in Venous blood

537

2519

1.79

33.22

4.3

3.5

25.14

25.02

mmol/l

0.36

523

2420

(3041096) Erythrocytes [Presence] in Urine by Automated

4095

28400

1.26

31.94

3.0

2.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

160

471

2.82

31.05

2.6

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5075

36214

1.24

30.35

2.5

2.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

680

3493

1.64

30.20

3.3

2.4

0.21

0.25

e6/l

0.43

663

3353

(3029937) Albumin [Presence] in Urine by Test strip

3703

25529

1.26

30.00

3.6

3.2

0.00

estimate

0.31

1284

9825

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4658

32967

1.24

29.93

2.3

2.2

—

(3015736) pH of Urine

5451

39402

1.22

28.21

3.3

2.8

6.04

6.01

0.31

466

4136

(3026008) Bacteria identified in Urine by Culture

3545

24607

1.25

26.44

2.5

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4896

35423

1.21

23.95

1.9

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11893

93823

1.24

21.38

4.1

3.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

126

402

2.60

21.13

31.7

24.5

108.01

120.75

ug/l

1.14

105

340

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2591

17745

1.25

21.09

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

2387

16258

1.25

20.32

2.7

108.31

117.39

ug/g

0.68

1891

12920

(3004119) Hemoglobin [Mass/volume] in Venous blood

628

3472

1.51

20.31

4.6

3.4

133.16

133.62

g/l

0.21

613

3393

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9978

77638

1.19

19.41

4.0

3.9

14.44

14.40

pmol/l

1.04

9207

71583

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4012

28971

1.20

18.96

1.4

1.58

1.71

u/ml

0.26

1215

7973

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6911

52271

1.17

18.71

3.1

2.9

73.03

74.41

ug/l

0.28

6625

49512

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

197

3.19

18.54

6.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

8498

65380

1.17

18.39

3.8

3.5

8.19

8.41

mm/h

1.29

8034

61100

(3019198) Lymphocytes [#/volume] in Blood

6523

49175

1.17

18.21

6.4

5.9

2.00

2.02

e9/l

0.53

6019

44436

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

380

1945

1.63

17.23

7.9

5.4

908.29

601.73

iu/ml

0.43

210

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3123

22236

1.20

16.87

2.2

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

736

4371

1.41

16.44

1.6

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

397

2082

1.59

16.31

3.7

5.3

0.87

0.94

2.36

374

1941

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3434

24818

1.18

15.48

2.6

2.5

56.50

61.26

u/l

0.73

3198

22987

(3013650) Neutrophils [#/volume] in Blood by Automated count

6996

53492

1.15

14.93

8.6

8.3

3.95

4.00

e9/l

1.26

6309

46992

(3024354) Oxygen [Partial pressure] in Venous blood

831

5128

1.36

14.72

5.3

3.8

4.78

4.84

kpa

0.31

807

4937

(3026782) Osmolality of Urine

2226

15533

1.21

14.62

3.1

2.5

533.86

557.76

mosm/kgh2o

0.63

1943

13258

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

394

2119

1.55

14.55

3.5

5.2

1.71

1.79

0.57

369

1972

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

291

1458

1.66

14.42

4.9

3.4

31812.00

782.69

u/ml

0.50

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1915

13180

1.23

14.40

2.4

6086.04

6918.17

u/l

0.53

762

5425

(3007853) Bacteria identified in Skin by Aerobe culture

1554

10474

1.25

14.16

1.7

1.6

—

(3013512) EKG study

2402

16963

1.20

13.85

3.0

2.7

—

(40761535) Cells panel - Urine sediment

867

5442

1.33

13.73

3.4

3.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

5849

44359

1.15

13.55

7.0

6.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5965

45362

1.14

13.13

2.2

2.1

—

(3002032) Base excess in Venous blood by calculation

958

6146

1.31

12.99

6.1

4.3

1.47

1.59

mmol/l

0.53

805

5081

(3051387) C reactive protein [Mass/volume] in Capillary blood

324

1714

1.57

12.92

2.9

3.0

24.18

24.61

mg/l

0.07

203

1025

(3021447) Carbon dioxide [Partial pressure] in Venous blood

962

6190

1.30

12.76

6.1

4.2

5.80

5.88

kpa

1.92

936

5973

(3018010) Neutrophils/100 leukocytes in Blood

6073

46357

1.14

12.38

6.2

5.7

55.61

55.80

0.68

5804

43938

(3013115) Eosinophils [#/volume] in Blood

6361

48706

1.14

12.35

6.8

6.2

0.18

0.19

e9/l

4.79

5799

43548

(3002030) Lymphocytes/100 leukocytes in Blood

6160

47072

1.14

12.33

6.4

5.9

30.59

30.26

1.72

5892

44630

(3007164) IgA [Mass/volume] in Serum or Plasma

3354

24589

1.16

12.18

1.4

2.03

2.11

g/l

2.91

2273

15514

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

797

5033

1.32

12.11

1.8

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

1037

6784

1.28

12.11

4.7

4.3

0.72

0.80

0.40

318

1939

(3037467) Urinalysis macro (dipstick) panel - Urine

8516

66532

1.13

11.74

4.2

3.7

—

(3025159) Blasts/100 leukocytes in Blood

964

6278

1.29

11.67

4.7

4.4

0.03

0.32

1.77

243

1434

(3001604) Monocytes [#/volume] in Blood

6126

46905

1.13

11.65

6.6

6.0

0.54

e9/l

0.74

5531

41372

(3006315) Basophils [#/volume] in Blood

6135

46986

1.13

11.61

6.6

6.0

0.04

e9/l

1.26

5533

41388

(3042733) HLA Ab [Presence] in Serum

326

2.26

11.31

5.2

4.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4741

35769

1.14

11.26

2.5

2.3

70.61

70.95

nmol/l

0.41

4484

33524

(3021440) Promyelocytes/100 leukocytes in Blood

993

6526

1.27

11.18

4.7

4.4

0.06

0.11

1.34

277

1683

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12402

99531

1.17

11.04

11.1

9.7

18.92

20.32

mg/l

5.41

9575

75015

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11248

89623

1.15

10.98

4.6

4.4

2.02

1.92

mu/l

0.15

10767

84627

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1065

7082

1.26

10.87

1.4

1.3

229.38

233.30

miu/ml

0.13

533

3504

(3026389) Candida sp identified in Specimen by Organism specific culture

284

1520

1.55

10.84

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

5598

42757

1.13

10.81

8.2

8.0

0.00

e9/l

0.79

4724

35128

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2908

21276

1.16

10.65

2.2

2.1

2.63

mg/l

0.01

2578

18269

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

247

2.41

10.63

3.6

2.5

—

(40761511) CBC panel - Blood by Automated count

13060

105360

1.20

10.42

10.2

8.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

8106

63375

1.12

10.38

4.1

3.8

1576.75

1289.13

e6/l

0.15

141

734

(3017143) Hepatitis C virus Ab [Presence] in Serum

2842

20795

1.16

10.37

1.8

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1022

6807

1.26

10.29

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

951

6315

1.26

9.83

4.3

4.0

0.47

0.55

0.80

276

1723

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

523

3216

1.35

9.58

1.9

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2875

21205

1.15

9.26

3.6

3.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4245

32181

1.12

8.82

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6178

47878

1.11

8.57

4.6

4.2

6.22

6.28

mmol/l

1.55

5473

42422

(3005322) IgE [Units/volume] in Serum or Plasma

1129

7761

1.22

8.48

1.3

218.60

283.77

u/ml

1.03

1057

7129

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

309

1776

1.44

8.46

1.4

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

765

5043

1.27

8.44

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

189

979

1.60

8.41

3.6

2.9

1.13

1.36

0.63

171

889

(3004716) Salmonella sp identified in Stool by Organism specific culture

1181

8179

1.21

8.22

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

278

2.11

7.81

2.0

1.7

3087.50

18451.89

u/ml

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1949

14165

1.16

7.62

1.5

59339173.54

34083186.62

pmol/l

0.91

1724

12276

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3232

24286

1.13

7.61

1.6

1.5

—

(3003338) MCHC [Mass/volume]

11598

93189

1.12

7.56

13.0

11.9

334.31

334.05

g/l

2.42

11500

92382

(3022096) Basophils/100 leukocytes in Blood

5529

42812

1.10

7.46

6.7

6.0

0.64

0.66

1.42

5217

40160

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1277

8993

1.19

7.41

2.1

2.0

389.89

383.44

nmol/l

0.47

1189

8301

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4717

36266

1.11

7.27

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3111

23429

1.12

6.98

2.7

2.6

30.05

47.57

ng/l

0.79

1417

9951

(3029634) Reagin Ab [Titer] in Serum by VDRL

382

2356

1.35

6.98

1.9

4.31

6.54

titre

0.33

(3022948) Iron [Moles/volume] in Serum or Plasma

1620

11691

1.16

6.95

2.7

2.3

27.02

14.72

umol/l

0.49

1533

10968

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

516

3323

1.29

6.93

1.4

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

5719

44473

1.10

6.91

6.6

5.9

2.66

2.78

3.90

5433

41916

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

236

1351

1.45

6.70

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

490

3154

1.29

6.63

1.4

1.3

216.58

231.63

u/ml

0.63

299

1985

(3025468) Yersinia sp identified in Specimen by Organism specific culture

175

950

1.53

6.47

1.5

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

892

6158

1.21

6.46

1.5

1.4

8.36

7.80

u/l

0.48

739

5042

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5810

45318

1.10

6.43

2.7

2.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

175

953

1.52

6.38

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

175

953

1.52

6.38

1.5

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4397

33865

1.10

6.35

7.6

5.9

1.21

mmol/l

0.12

3812

28894

(40768446) Kidney Pathology biopsy report

396

1.82

6.32

2.0

1.7

—

(3045414) Leukocytes [Presence] in Urine

577

3815

1.26

6.30

1.6

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

5739

44777

1.09

6.26

6.8

6.2

8.09

8.03

0.67

5457

42275

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2812

21198

1.12

6.11

1.5

—

(3022621) pH of Urine by Test strip

806

5546

1.21

6.06

2.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

175

966

1.50

6.01

1.6

1.4

—

(3025941) Bacteria identified in Stool by Culture

942

6586

1.19

5.97

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

174

964

1.50

5.88

1.6

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

347

1.84

5.81

2.1

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

445

2884

1.28

5.76

1.8

1.4

10.98

22.00

u/ml

1.93

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1109

7887

1.17

5.75

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

266

1606

1.37

5.65

1.4

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

119

611

1.61

5.65

1.1

1.0

14.76

14.84

u/ml

0.01

382

(3035941) MCH [Entitic mass]

14032

114586

1.21

5.65

15.7

14.2

29.90

29.91

0.50

13900

113346

(3026361) Erythrocytes [#/volume] in Blood

14034

114615

1.21

5.56

15.8

14.2

4.58

4.59

e12/l

2.54

13765

111830

(3024731) MCV [Entitic volume]

14031

114589

1.20

5.55

15.7

14.2

89.17

89.30

3.07

13898

113348

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

176

990

1.47

5.55

1.6

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1455

10593

1.15

5.53

2.0

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

442

2880

1.27

5.50

1.8

1.4

—

(3045424) Erythrocytes [Presence] in Urine

237

1412

1.39

5.47

1.4

—

(3010813) Leukocytes [#/volume] in Blood

14034

114635

1.20

5.40

15.8

14.3

6.74

6.79

e9/l

2.47

13751

111832

(3002385) Erythrocyte distribution width [Ratio]

11188

90158

1.10

5.40

12.8

11.8

14.27

14.51

0.27

11016

88512

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

421

2739

1.28

5.32

1.8

1.4

104.13

104.84

u/ml

0.05

103

561

(3000963) Hemoglobin [Mass/volume] in Blood

14038

114685

1.20

5.29

15.9

14.3

136.38

136.84

g/l

3.89

13905

113448

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

314

1970

1.32

5.22

1.6

1.7

3526.67

3243.28

titre

0.04

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

127

679

1.55

5.13

2.0

1.7

—

(3007461) Platelets [#/volume] in Blood

14008

114441

1.19

5.11

15.9

14.3

260.43

260.51

e9/l

0.05

13750

111846

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

369

2375

1.29

5.09

1.4

12.70

14.67

u/l

1.16

329

2004

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

145

800

1.50

5.07

2.0

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1442

10556

1.14

5.06

2.8

2.3

2.47

2.48

g/l

0.33

1364

9772

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

419

2743

1.27

5.05

1.6

—

(3000494) Fungus identified in Specimen by Culture

1296

9421

1.15

5.04

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

454

3004

1.25

5.01

2.2

1.9

—

(3024471) HLA-A [Type]

328

1.79

5.00

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

392

2551

1.28

4.97

7.6

5.6

1.35

1.25

mg/l

2.37

372

2423

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1640

15057

0.89

4.92

2.0

2.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1226

8900

1.15

4.87

1.7

1.8

—

(3024932) HLA-DR beta [Type]

325

1.78

4.86

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

160

910

1.46

4.83

1.3

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.59

4.83

9.2

7.4

6.35

5.90

mmol/l

0.17

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

115

611

1.56

4.80

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

878

6224

1.17

4.78

2.1

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1006

7211

1.16

4.76

2.7

2.5

10.39

10.50

g/l

0.48

945

6620

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

580

3963

1.22

4.76

1.1

2.99

2.66

u/ml

0.21

326

2114

(3015171) Extractable nuclear Ab [Units/volume] in Serum

560

3814

1.22

4.75

1.3

0.56

0.91

u/ml

0.46

279

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.79

4.72

4.8

4.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3597

27775

1.09

4.67

8.4

7.5

1.09

1.10

inr

0.07

1218

9687

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

749

5254

1.19

4.64

3.8

3.5

1.23

1.22

mmol/l

0.50

641

4573

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1486

10964

1.13

4.62

1.9

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

459

3071

1.24

4.62

2.1

1.9

0.22

g/l

0.43

439

2931

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

683

1.51

4.62

3.6

3.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

971

6959

1.16

4.61

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

527

3579

1.22

4.61

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

124

677

1.52

4.60

7.4

6.6

10.00

10.19

mg/l

0.20

117

622

(3008152) Bicarbonate [Moles/volume] in Arterial blood

479

3229

1.23

4.50

5.8

6.9

24.15

24.16

mmol/l

0.01

453

3058

(3009542) Hematocrit [Volume Fraction] of Blood

13986

114335

1.17

4.46

15.8

14.3

40.61

41.00

0.57

13355

109146

(3002582) Erythrocytes [#/volume] in Urine

3141

24160

1.09

4.42

3.3

2.8

37.32

78.96

e6/l

3.51

2489

17875

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.75

4.41

4.4

4.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

293

1868

1.30

4.41

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

755

5330

1.18

4.35

2.8

2.2

78.25

81.60

ml/min/173m2

1.10

263

1912

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

468

3160

1.23

4.35

2.1

1.9

1.15

1.16

g/l

0.21

450

3019

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1007

7272

1.15

4.33

4.4

4.1

221.31

228.73

u/l

1.14

970

6923

(3003888) Timothy IgE Ab [Units/volume] in Serum

518

3547

1.21

4.20

1.1

7.85

7.61

u/ml

0.08

299

2045

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1301

9584

1.13

4.17

3.0

2.4

24.25

24.35

0.09

1154

8316

(3009445) Proteinase 3 Ab [Units/volume] in Serum

471

3199

1.22

4.15

1.5

1.6

9.98

11.56

u/ml

0.11

127

(3013727) Leukocytes other/100 leukocytes in Blood

203

1.91

4.14

3.7

3.2

54.93

49.58

1.18

196

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

422

2835

1.23

4.13

1.6

7.41

7.45

mmol/l

0.15

413

2713

(3018095) Leukocytes [#/volume] in Urine

3934

30634

1.08

4.09

3.8

3.2

74.00

66.03

e6/l

0.23

2711

19584

(3039162) Centromere protein B Ab [Units/volume] in Serum

194

1179

1.36

4.08

1.3

23.51

48.16

u/ml

1.15

(3023368) Bacteria identified in Blood by Culture

2255

17142

1.10

4.08

4.2

3.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

252

1.80

4.06

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

176

1.97

4.04

2.2

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

247

1.81

4.01

3.3

3.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

197

1206

1.35

3.97

2.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

197

1207

1.35

3.95

2.2

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

490

3360

1.21

3.94

1.1

0.94

1.38

u/ml

1.40

231

1598

(3020779) Urea [Moles/volume] in Serum or Plasma

759

5409

1.17

3.93

13.2

8.2

7.85

7.19

mmol/l

2.37

741

5200

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

853

1.42

3.90

1.9

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1809

13633

1.11

3.89

1.4

523.79

548.02

titre

0.21

306

2435

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

601

4206

1.19

3.88

6.8

4.2

89.69

78.07

ng/l

1.99

554

3822

(3003694) ABO and Rh group [Type] in Blood

4916

38669

1.07

3.86

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

888

6415

1.15

3.83

3.7

3.1

1.64

1.66

0.23

813

5758

(3033658) Prothrombin time (PT) actual/Normal

2263

20165

0.91

3.82

4.5

3.6

95.54

94.74

0.93

2202

19586

(3019309) Folate [Moles/volume] in Red Blood Cells

1377

10245

1.12

3.75

1.6

1163.44

1161.58

nmol/l

0.02

1110

7980

(3020961) Endomysium IgA Ab [Titer] in Serum

926

6723

1.15

3.73

1.2

1.1

351.25

146.86

titre

1.19

199

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1187

8765

1.13

3.68

10.0

6.3

1.10

1.08

mmol/l

2.28

1137

8271

(3050129) First trimester maternal screen panel - Serum or Plasma

1698

12798

1.11

3.65

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

129

749

1.42

3.60

1.7

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

407

2768

1.22

3.60

2.0

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

1144

1.34

3.54

1.8

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1420

10625

1.11

3.51

5.2

3.7

0.82

0.83

mmol/l

1.03

1355

10052

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

101

2.21

3.51

3.4

3.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4967

39185

1.07

3.51

5.7

5.0

9.88

10.51

umol/l

4.58

4648

36643

(3048879) Bone marrow aspiration report

2.24

3.48

2.8

2.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1052

7750

1.13

3.41

5.5

4.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

179

1109

1.34

3.40

1.5

1.4

—

(3019060) Gas panel - Arterial blood

458

3171

1.20

3.39

4.0

5.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

250

1.72

3.33

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

112

644

1.44

3.33

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2081

15912

1.09

3.31

1.3

18.38

24.38

iu/ml

1.93

612

4657

(3043410) Blood group antigens tested for on Red Blood Cells

257

1.70

3.29

1.2

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1337

10011

1.11

3.27

1.2

112.54

145.17

iu/ml

2.78

526

3743

(3027944) Amphetamines [Presence] in Urine

1566

11825

1.10

3.26

1.8

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

893

8289

0.88

3.25

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.95

3.24

4.7

2.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

443

3074

1.19

3.22

2.2

2.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7817

62673

1.06

3.21

7.1

6.3

72.01

72.97

u/l

1.15

7435

59105

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1950

14891

1.09

3.20

1.3

9.43

8.02

u/ml

0.38

838

6087

(3015235) Bicarbonate [Moles/volume] in Capillary blood

250

1639

1.26

3.14

3.6

2.9

23.67

24.06

mmol/l

1.08

244

1592

(3000850) Epithelial cells [#/volume] in Urine

2157

16560

1.09

3.13

2.7

2.4

7.17

7.88

e6/l

1.20

1935

14650

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

316

2128

1.23

3.13

1.1

8.76

12.29

au/ml

0.63

174

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10374

83939

1.07

3.10

3.1

5.53

5.58

mmol/l

2.53

9793

78482

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1481

11185

1.10

3.08

2.9

2.8

972.56

832.75

ng/l

0.58

1199

8789

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

225

1.73

3.08

2.4

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

472

3308

1.18

3.08

1.2

—

(3028433) Virus identified in Specimen by Culture

288

1.64

3.07

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

153

944

1.34

3.03

1.6

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.55

3.03

7.2

5.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

244

1604

1.26

3.01

2.2

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

548

1.45

3.00

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

178

1.81

3.00

1.2

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

607

4350

1.16

3.00

3.1

2.9

69.37

71.60

e9/l

0.67

446

3156

(40768804) Tissue Pathology biopsy report

4257

33555

1.07

3.00

1.9

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

267

1775

1.25

2.99

1.9

2.1

1.81

1.83

ug/l

0.01

241

1579

(3011412) CD3 cells [#/volume] in Blood

166

1041

1.32

2.95

2.7

2.6

1.33

1.34

e9/l

0.05

148

908

(3028300) Cannabinoids [Presence] in Urine

1587

12054

1.10

2.94

2.0

2.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1371

10345

1.10

2.91

2.7

2.4

29.25

29.46

0.70

1320

10003

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

131

795

1.36

2.90

2.4

2.3

—

(3027008) Opiates [Presence] in Urine

1582

12026

1.10

2.88

1.9

2.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

490

3467

1.17

2.87

1.1

2.54

2.64

u/ml

0.06

272

1890

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

266

1777

1.24

2.87

1.3

1.2

36.06

12.04

u/ml

—

(3017704) Immunofixation for Urine

193

1.75

2.87

2.0

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

216

1409

1.27

2.86

2.9

2.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

142

875

1.34

2.86

2.1

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

142

876

1.34

2.84

2.1

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

533

3801

1.16

2.83

2.1

7.14

6.56

ug/l

0.22

480

3327

(3010144) Erythrocytes [#/volume] in Synovial fluid

487

1.46

2.83

1.5

1.4

22545.42

73503.77

e6/l

1.27

338

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

307

2086

1.22

2.82

1.3

1.2

40.49

38.67

u/ml

0.06

178

(3014133) Dog dander IgE Ab [Units/volume] in Serum

415

2901

1.19

2.82

1.1

5.86

4.77

u/ml

0.31

228

1527

(3028026) IgM [Mass/volume] in Serum or Plasma

756

5528

1.14

2.81

1.8

1.7

1.25

1.27

g/l

0.18

714

5138

(3024980) IgG subclass 4 [Mass/volume] in Serum

249

1657

1.24

2.79

1.7

1.6

0.68

0.73

g/l

0.44

203

1270

(3023430) Cat dander IgE Ab [Units/volume] in Serum

386

2684

1.19

2.79

1.1

8.51

6.33

u/ml

0.64

187

1249

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

339

2330

1.21

2.78

1.3

2.50

10.78

u/ml

3.06

227

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

482

1.46

2.78

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

112

1.99

2.77

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1569

11947

1.09

2.76

2.0

2.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

139

859

1.34

2.76

2.8

3.0

41479.19

41181.83

ug/l

0.07

139

859

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

305

2078

1.22

2.74

2.7

2.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

168

1069

1.30

2.72

1.3

0.43

0.37

g/l

1.52

133

741

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3512

27589

1.07

2.72

1.7

98.87

97.65

pmol/l

0.92

2030

15431

(3028192) IgG subclass 2 [Mass/volume] in Serum

168

1070

1.30

2.71

1.3

2.98

2.90

g/l

0.23

134

744

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

273

1842

1.23

2.71

1.3

1.28

5.18

u/ml

1.43

118

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

133

820

1.34

2.69

2.8

2.6

555.42

547.36

e6/l

0.08

110

677

(3017354) Segmented neutrophils/100 leukocytes in Blood

575

1.41

2.68

3.4

2.8

55.93

53.03

0.81

498

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

332

1.54

2.67

1.7

1.3

—

(3005033) Fetal Nuchal fold Thickness US

884

8105

0.89

2.66

1.4

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

172

1102

1.29

2.66

2.2

1.6

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

6.19

2.65

1.3

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2181

19178

0.93

2.65

1.6

1.35

1.37

mmol/l

0.40

1964

16834

(3021387) Prolactin [Units/volume] in Serum or Plasma

1174

8844

1.10

2.60

1.5

1.6

332.30

313.26

mu/l

0.34

1058

7872

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

373

2604

1.19

2.60

1.3

30.94

39.82

u/ml

0.21

161

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

535

3845

1.15

2.59

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

167

1070

1.29

2.59

1.3

6.51

6.65

g/l

0.26

132

743

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

863

7907

0.89

2.58

2.6

2.4

38.60

45.92

u/l

0.36

747

6837

(44813793) Dust mix specific IgE antibody measurement

158

1006

1.30

2.57

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1246

9423

1.10

2.56

2.1

2.4

—

(4034850) Laboratory test

342

2374

1.19

2.55

8.7

7.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1018

9238

0.90

2.54

3.1

21.50

21.39

0.06

354

3124

(4062490) Immunoglobulin typing, IgG

167

1074

1.29

2.53

1.5

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

381

2674

1.18

2.51

1.6

95.00

366.10

titre

—

100

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

569

1.39

2.51

2.3

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

576

1.39

2.51

1.1

14.90

u/ml

0.00

112

(3038177) Helicobacter pylori Ab [Presence] in Serum

287

1964

1.21

2.50

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

511

3673

1.15

2.49

1.6

0.71

0.47

iu/ml

0.18

709

(3018405) Lactate [Moles/volume] in Arterial blood

267

1818

1.22

2.46

3.5

3.9

1.42

1.39

mmol/l

0.09

262

1790

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

869

1.31

2.45

1.2

—

(3004775) Volume in Urine collected for unspecified duration

394

1.47

2.42

2.5

2.4

633.11

645.12

0.07

298

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

327

1.52

2.42

1.7

1.3

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

0.66

1.65

mg/l

1.19

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

1.21

1.36

mg/l

0.14

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

1.32

2.42

mg/l

0.82

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

2.07

1.39

mg/l

0.20

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

3.65

4.41

mg/l

0.21

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

0.72

2.80

mg/l

2.95

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

1.95

1.47

mg/l

0.13

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

0.91

1.82

mg/l

1.06

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

124

1.86

2.42

1.7

1.6

0.40

0.94

mg/l

1.50

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

138

871

1.31

2.42

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2449

19083

1.07

2.41

2.1

237.88

234.27

u/l

0.04

2336

18078

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

201

1331

1.25

2.41

2.3

2.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

243

1643

1.22

2.41

2.3

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1013

7610

1.11

2.40

1.4

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3012

23635

1.06

2.40

2.8

2.34

2.35

mmol/l

1.88

2752

21406

(3024561) Albumin [Mass/volume] in Serum or Plasma

3866

30565

1.06

2.40

5.4

4.6

37.34

37.29

g/l

0.26

3638

28499

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

130

815

1.32

2.39

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

107

1.93

2.39

1.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

180

1.70

2.36

1.4

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

339

2374

1.18

2.32

1.3

17.91

14.74

u/ml

0.14

340

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

741

6798

0.89

2.30

2.3

0.61

0.65

ug/l

0.34

389

3496

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

205

0.40

2.29

13.6

7.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11218

91262

1.06

2.29

10.7

9.4

139.45

139.50

mmol/l

2.32

10905

88409

(3022493) Free Hemoglobin [Mass/volume] in Plasma

352

1.48

2.28

3.4

5.1

68.62

3852.42

mg/l

2.10

253

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1593

12245

1.08

2.28

3.1

2.5

3.87

3.94

e6/l

0.08

953

6147

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

139

1.78

2.27

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.02

2.27

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

894

8113

0.90

2.27

1.4

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

574

0.65

2.26

2.1

2.3

139.15

155.20

nmol/l

0.52

483

(3052851) Hemolysis interference index of Serum or Plasma

229

2290

0.82

2.26

3.3

2.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

143

917

1.29

2.25

2.1

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

261

1.55

2.22

1.9

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

261

1.55

2.22

1.9

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

128

1.81

2.22

1.7

1.6

0.98

1.70

mg/l

0.73

(3051101) Glucose [Moles/volume] in Cord blood

2.29

2.20

5.7

5.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

674

4979

1.12

2.20

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

128

812

1.30

2.20

2.8

2.7

0.18

0.21

e9/l

1.42

108

683

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

942

7087

1.10

2.19

1.7

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

349

2465

1.17

2.18

1.1

—

(36660697) Celiac disease serology panel - Serum

1363

10432

1.09

2.17

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

547

3993

1.14

2.17

1.5

1.7

40.93

40.15

nmol/l

0.21

539

3928

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

961

7241

1.10

2.17

1.8

1.6

—

(3016031) Almond IgE Ab [Units/volume] in Serum

160

1.70

2.16

1.1

0.63

0.75

u/ml

0.12

102

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1333

11839

0.92

2.12

2.9

2.8

729.98

487.41

ng/l

0.64

686

6136

(3000093) Morphology [Interpretation] in Blood Narrative

104

645

1.33

2.11

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

184

1228

1.24

2.11

2.7

2.5

24.84

23.79

nmol/l

0.53

175

1184

(3016879) Cocaine [Presence] in Urine

1451

11153

1.08

2.09

2.0

2.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1704

13181

1.08

2.08

1.6

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

11241

91529

1.06

2.08

10.8

9.5

3.90

mmol/l

0.24

10896

88389

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

125

798

1.29

2.07

2.9

2.2

95.40

97.31

0.26

117

723

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

306

1.48

2.06

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

471

1.39

2.06

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

590

4345

1.13

2.05

5.0

3.5

5.09

5.11

kpa

0.29

573

4148

(3037121) Protein [Mass/volume] in Urine

376

2692

1.16

2.00

3.4

0.43

0.34

g/l

0.35

198

1334

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1450

12799

0.93

1.98

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

339

2411

1.16

1.98

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

532

1.35

1.96

2.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

532

1.35

1.96

2.2

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

532

1.35

1.96

2.2

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

812

6104

1.10

1.95

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1928

15015

1.07

1.95

1.5

1.4

20.33

19.71

nmol/l

1.22

1735

13423

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1007

9014

0.92

1.95

1.2

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1132

10082

0.92

1.95

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

2791

21987

1.06

1.94

3.3

2.8

0.27

0.28

e6/l

0.12

2159

16095

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1356

11989

0.93

1.94

3.6

3.4

2.29

1.81

ug/l

0.41

1251

10900

(3009343) pH of Capillary blood

582

4299

1.12

1.94

5.0

3.5

7.41

0.16

566

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

284

1.48

1.93

2.9

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

284

1.48

1.93

2.9

2.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

142

0.41

1.93

1.4

1.3

—

90.85

—

(3032773) Endomysium IgG Ab [Titer] in Serum

174

1168

1.23

1.92

1.2

1.1

—

48.00

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

141

1.70

1.91

1.7

—

(3011648) Oxygen content in Venous blood

570

1.33

1.91

4.2

3.8

11.04

11.34

0.38

570

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

436

3170

1.14

1.88

3.6

2.7

159.78

166.05

0.84

419

2999

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

1.88

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

421

3056

1.14

1.87

1.2

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

396

1.40

1.86

1.2

1.3

799.37

338.37

u/l

0.47

366

(3014765) Yersinia sp identified in Stool by Organism specific culture

423

3073

1.14

1.86

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

136

1.70

1.86

3.8

2.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

233

1.52

1.85

1.0

0.25

0.55

u/ml

0.78

130

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

552

1.33

1.84

2.1

2.4

9.90

9.56

mg/l

0.24

448

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

432

1.38

1.84

1.2

111.68

108.65

0.47

385

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.24

1.83

1.0

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

553

1.33

1.82

2.4

2.5

12.30

10.83

0.46

533

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

482

1.35

1.82

1.7

1.8

2.66

2.16

u/field

0.25

263

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1132

10052

0.92

1.82

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

566

4192

1.12

1.82

5.1

3.5

1.26

1.16

mmol/l

0.30

389

2900

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

187

1273

1.21

1.82

3.7

3.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

398

1.39

1.82

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

267

1878

1.18

1.82

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

425

3095

1.14

1.81

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

194

1329

1.21

1.78

1.3

6.53

6.39

umol/l

0.22

180

1249

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1139

10099

0.92

1.77

1.4

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.82

1.76

1.8

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

263

1.48

1.76

2.4

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

263

1.48

1.76

2.4

2.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2517

19830

1.06

1.75

2.0

1.9

1.00

0.98

mg/l

0.06

1793

13946

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.04

1.75

1.6

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

537

1.32

1.72

3.4

3.1

102.83

85.68

mg/l

0.17

400

(3010503) CD19 cells [#/volume] in Blood

538

1.32

1.70

2.8

2.7

0.16

0.32

e9/l

1.16

529

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1.56

1.70

4.7

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

185

1.56

1.70

4.7

2.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

185

1.56

1.70

1.5

1.2

—

(3025130) Human papilloma virus identified in Specimen

238

2302

0.85

1.70

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

528

3914

1.12

1.70

1.1

3.21

4.18

u/ml

0.64

595

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

507

0.68

1.69

1.1

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

450

3306

1.13

1.69

3.3

2.9

3.46

3.54

g/l

0.52

429

3122

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1142

10102

0.93

1.69

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

164

1113

1.22

1.67

2.4

1.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

328

1.41

1.67

2.1

2.2

119.64

118.70

ng/l

0.02

259

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

370

2687

1.14

1.67

2.3

2.1

1.28

1.30

g/l

0.14

326

2349

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.89

1.66

1.0

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

172

1174

1.21

1.66

2.8

3.1

26.06

29.10

mu/l

0.49

160

1097

(3047181) Lactate [Moles/volume] in Blood

289

2064

1.16

1.65

4.1

5.2

1.28

1.20

mmol/l

0.53

254

1810

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

470

1.34

1.64

1.2

0.30

0.29

g/l

0.60

378

(3002079) Sodium [Moles/time] in 24 hour Urine

462

0.68

1.60

1.9

1.3

151.04

161.39

mmol/24h

0.38

462

(40757373) Influenza virus identified in Isolate

117

1.69

1.60

2.3

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

451

1.34

1.59

2.4

213.72

219.36

e6/l

0.04

266

(3008116) Ketones [Moles/volume] in Urine by Test strip

182

1.54

1.58

1.6

1.4

—

(4200892) Spirometry reversibility

675

5090

1.10

1.58

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

270

1.44

1.57

2.4

2.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

295

2120

1.15

1.57

1.4

1.5

17.55

6.17

iu/ml

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

746

0.75

1.56

3.3

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

746

0.75

1.56

6.5

6.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

132

0.44

1.56

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

145

981

1.22

1.55

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

119

788

1.25

1.55

1.1

1527.63

1478.35

miu/ml

0.19

119

788

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

119

789

1.25

1.54

1.4

1.2

3.45

2.82

u/ml

0.27

432

(21494814) CD8 cells/100 lymphocytes in Specimen

348

1.38

1.53

2.2

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

158

1.57

1.51

1.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

218

1.48

1.51

1.0

—

(3016502) Oxygen saturation in Arterial blood

697

5279

1.09

1.50

7.3

8.4

96.72

96.31

1.16

665

5073

(3028679) Herpes simplex virus Ab [Presence] in Serum

145

985

1.22

1.50

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

165

1.55

1.49

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

336

1.38

1.49

2.6

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

336

1.38

1.49

2.6

1.9

—

(3045788) Cell count panel - Pleural fluid

295

0.61

1.48

1.4

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

114

756

1.25

1.48

1.1

5.31

7.51

iu/ml

1.22

210

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.02

1.48

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

113

1151

0.81

1.45

2.0

1.7

—

(3019977) pH of Arterial blood

282

1.41

1.45

4.0

2.8

7.43

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

441

3274

1.11

1.43

1.6

1.5

0.40

0.46

nmol/l

0.83

371

2762

(3020891) Body temperature

295

2137

1.14

1.43

4.6

4.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

476

3549

1.11

1.43

2.0

1.9

38.91

39.11

u/l

0.08

442

3315

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.32

1.42

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

195

1370

1.18

1.42

1.2

40.00

259.29

titre

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1021

7876

1.07

1.42

2.1

10.82

11.37

nmol/l

1.18

935

7211

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

168

1.52

1.40

1.1

9.49

11.12

u/ml

0.20

118

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

299

2793

0.88

1.38

11.0

10.6

23.86

24.00

mmol/l

0.39

294

2715

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

183

1284

1.18

1.36

2.7

2.5

41.50

154.71

ug/min

7.08

130

846

(3012501) Base excess in Blood by calculation

176

1706

0.85

1.36

3.3

3.5

1.78

2.07

mmol/l

1.09

106

979

(3010421) pH of Blood

205

1963

0.86

1.36

3.5

3.6

7.41

0.60

185

1776

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.17

1.35

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

245

1.42

1.34

2.8

2.6

27.48

29.03

umol/l

0.36

169

(3024891) Influenza virus A+B Ag [Presence] in Specimen

347

3201

0.89

1.32

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

144

1.55

1.32

1.0

1.1

8.34

7.13

mmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.45

1.31

4.1

2.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

316

2315

1.13

1.31

1.1

0.21

0.38

u/ml

0.75

626

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

395

1.32

1.30

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

345

1.34

1.30

1.6

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

294

2735

0.88

1.29

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

610

0.76

1.28

3.0

2.9

145.52

180.94

umol/l

0.41

315

(3003181) Sodium [Moles/volume] in Urine

786

0.79

1.28

1.7

1.6

68.65

70.66

mmol/l

0.13

638

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3846

30836

1.04

1.27

3.5

3.0

30.12

30.39

u/l

0.10

3685

29340

(3021788) Differential panel - Synovial fluid

110

1104

0.82

1.27

1.6

—

(3016228) CD19 cells/100 cells in Blood

354

1.33

1.26

2.2

2.1

9.54

9.46

0.02

347

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

113

1.61

1.26

3.4

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

289

2113

1.13

1.25

2.3

2.5

317.09

497.12

ug/l

0.65

254

1900

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

172

1213

1.17

1.23

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

269

1960

1.13

1.23

1.3

2.54

3.67

u/ml

0.88

707

(3003740) Influenza virus B Ag [Presence] in Specimen

295

2734

0.89

1.23

1.1

—

(21494434) Karyotype in Bone marrow

406

1.30

1.23

1.2

—

(3039000) Anion gap in Blood

174

1229

1.17

1.23

4.9

7.1

11.16

11.41

mmol/l

0.39

152

1101

(3022145) Colonoscopy Study observation

1103

8582

1.07

1.23

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

501

1.27

1.22

1.1

95.80

95.43

0.05

215

(3018572) Chloride [Moles/volume] in Blood

174

1230

1.17

1.22

4.9

7.1

105.17

105.70

mmol/l

0.73

152

1102

(3028626) Oxygen [Partial pressure] in Capillary blood

288

2110

1.13

1.22

5.7

3.8

9.31

9.25

kpa

0.19

280

2043

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

510

1.26

1.20

1.1

1.2

113.32

109.65

0.31

447

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

258

1880

1.13

1.19

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

890

6883

1.07

1.19

3.2

3.4

4.73

4.68

pmol/l

0.64

814

6218

(3021901) Oxygen saturation in Capillary blood

165

1164

1.17

1.19

2.2

2.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

128

1.55

1.19

1.7

1.8

—

(3011288) Drugs identified in Urine by Screen method

1077

8384

1.06

1.19

2.6

3.2

—

(3045142) Bone marrow Pathology biopsy report

555

1.25

1.18

1.3

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

344

1.32

1.18

1.8

1.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

252

1.38

1.17

1.0

1.32

0.96

u/ml

0.10

138

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1620

12766

1.05

1.17

3.0

2.4

0.99

1.02

e6/l

0.10

986

6658

(43055514) Macroprolactin [Presence] in Serum or Plasma

100

675

1.22

1.17

1.2

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

252

1837

1.13

1.17

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

257

1877

1.13

1.16

1.3

3.23

4.13

u/ml

0.84

132

854

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

153

1076

1.17

1.16

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

127

0.52

1.15

2.8

9.3

—

(3032057) Clostridioides difficile [Presence] in Stool

103

1.60

1.15

2.5

1.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

303

1.34

1.14

3.4

3.2

—

(3014051) Protein [Presence] in Urine by Test strip

295

2176

1.12

1.13

1.9

2.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

618

1.23

1.13

1.1

28.49

25.13

u/ml

0.04

391

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.69

1.12

2.1

2.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.31

1.11

6.7

8.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

933

0.82

1.10

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

494

1.25

1.10

1.9

1.5

5.12

6.33

u/l

1.65

414

(4281824) Cell count and differential, peritoneal fluid

613

0.78

1.10

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

171

0.58

1.08

9.0

5.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.97

1.08

2.2

3.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

191

0.60

1.07

1.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

3485

27984

1.04

1.06

2.3

2.0

—

(3016750) Collection duration of Urine

336

1.30

1.06

2.4

2.3

509.07

509.61

min

0.01

269

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

114

789

1.19

1.06

1.4

11.11

10.56

umol/l

0.40

109

749

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

246

1805

1.13

1.05

1.1

3720.20

5047.06

iu/ml

0.09

540

(40758292) HTLV I+II Ab panel - Serum

208

1.39

1.05

1.5

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

288

0.69

1.04

1.6

1.9

6.86

103.21

ug/min

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

199

0.62

1.03

1.1

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

133

1.49

1.03

1.4

1.2

0.31

173.26

mg/l

1.92

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

326

0.71

1.03

1.2

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

433

1.26

1.02

1.6

1.9

373.20

142.62

au/ml

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.92

1.02

1.0

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1220

9583

1.05

1.02

1.5

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

118

823

1.18

1.02

1.5

1.3

1.90

1.79

mmol/l

0.46

108

772

(3001729) Color of Synovial fluid

1.90

1.01

2.2

1.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

508

1.24

1.01

1.1

1.4

7.60

5.96

nmol/l

2.46

487

(3037756) Immunofixation for Serum or Plasma

681

1.20

1.00

2.0

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

253

1.34

0.99

1.0

1.1

0.74

4.92

u/ml

0.91

128

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.86

0.99

2.9

7.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.86

0.99

3.2

3.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

487

1.24

0.99

1.1

1.2

97.74

96.49

0.13

213

(40768800) Prostate Pathology biopsy report

481

0.77

0.96

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

397

0.75

0.96

3.0

0.71

0.82

nmol/l

1.04

296

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

282

2100

1.11

0.96

1.5

1.6

6.32

6.46

mmol/l

0.57

256

1929

(3000570) Elastase.pancreatic [Mass/mass] in Stool

252

1865

1.12

0.96

1.4

299.48

312.36

ug/g

0.38

125

939

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10493

85796

1.03

0.95

8.7

8.0

99.73

98.49

ml/min/173m2

6.62

8285

67726

(3002173) Hemoglobin [Mass/volume] in Arterial blood

647

4998

1.07

0.95

7.3

8.7

123.35

124.45

g/l

0.68

625

4861

(3003327) Ova and parasites identified in Stool by Light microscopy

592

4561

1.07

0.94

1.6

1.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.25

0.94

4.0

1.7

—

(3044889) 12 lead EKG panel

6258

52462

0.97

0.94

2.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

367

0.74

0.93

1.7

1.6

5.62

6.16

u/l

0.09

309

(3023323) Follitropin [Units/volume] in Serum or Plasma

986

7723

1.06

0.93

1.5

1.4

13.94

16.26

iu/l

2.02

838

6466

(3022689) Creatine [Moles/volume] in Urine

185

1.38

0.93

1.2

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.74

0.93

1.2

151.00

60.28

ug/l

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

231

1705

1.12

0.93

2.3

2.1

135.06

133.99

g/l

0.31

181

1338

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

290

0.71

0.92

2.9

2.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

507

1.22

0.92

2.7

44.42

43.92

0.09

284

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

315

1.28

0.91

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

315

1.28

0.91

1.1

—

(3045716) Anion gap in Serum or Plasma

299

0.72

0.91

2.9

2.7

9.62

10.10

mmol/l

0.29

290

(3019225) pH of Specimen

765

5953

1.06

0.91

3.8

3.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.56

0.91

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

125

1195

0.86

0.90

1.9

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

294

1.29

0.90

2.0

1.4

12.65

12.01

u/l

0.24

287

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.94

0.89

1.0

—

(3006270) Folate [Moles/volume] in Blood

569

1.20

0.89

1.1

383.05

410.15

nmol/l

0.66

539

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

331

1.27

0.89

2.0

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

117

828

1.17

0.88

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

666

5168

1.07

0.87

2.6

3.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

443

1.23

0.87

1.1

24.77

7.00

u/ml

0.56

315

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

171

1246

1.13

0.87

1.1

95.94

93.61

0.56

163

1171

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

132

1.44

0.86

4.4

4.9

42.75

40.00

ug/min

0.04

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

117

830

1.16

0.86

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

754

0.83

0.86

2.0

1.7

703358.33

1819000.61

iu/ml

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

253

1.31

0.85

1.1

1.0

0.06

0.25

u/ml

1.92

155

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

595

4605

1.07

0.85

1.3

1.2

3.71

3.72

ug/l

0.02

572

4393

(3001964) Herpes simplex virus Ag [Presence] in Specimen

304

1.28

0.85

2.0

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

505

1.21

0.84

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

117

832

1.16

0.84

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

161

1.38

0.83

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12522

102755

1.04

0.82

8.5

7.7

26.26

26.80

u/l

1.67

12167

99571

(3022313) Gas panel - Capillary blood

399

3050

1.08

0.81

5.7

3.7

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.76

0.81

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

102

720

1.17

0.81

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

293

2210

1.10

0.81

1.9

10.46

10.23

mg/l

0.20

269

2095

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

447

3434

1.08

0.80

3.0

2.6

96.45

94.64

1.03

432

3292

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.69

0.79

2.3

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1258

10806

0.96

0.79

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

117

837

1.15

0.79

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

315

1.26

0.79

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

243

0.71

0.79

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1114

8802

1.05

0.79

2.0

1.9

—

(3009677) Dengue virus Ab [Presence] in Serum

1.60

0.78

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

117

838

1.15

0.78

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

252

0.72

0.78

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

601

1.18

0.78

2.8

2.7

1.66

1.71

g/24h

0.06

337

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

250

1.29

0.77

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.17

0.76

1.0

3.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

251

1.28

0.75

2.1

—

(3003396) Base excess in Arterial blood by calculation

768

6020

1.06

0.75

6.9

7.9

0.74

0.61

mmol/l

0.38

572

4563

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

117

841

1.15

0.75

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.58

0.74

3.0

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

121

873

1.14

0.74

1.1

1.3

77.80

37.14

u/l

0.66

104

766

(3008295) Osmolality of Serum or Plasma

741

0.85

0.74

2.2

1.9

286.49

285.61

mosm/kgh2o

0.17

585

(3013336) Amino acids [Identifier] in Serum or Plasma

1.65

0.74

1.1

3.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

109

1.44

0.73

1.1

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

137

1.39

0.73

1.3

1.1

0.71

0.68

umol/24h

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

416

1.21

0.73

1.1

0.69

3.45

u/ml

1.03

360

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

497

0.81

0.72

2.6

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.75

0.71

1.1

7.73

8.35

mmol/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

103

1.44

0.71

1.1

2.42

1.99

u/ml

0.07

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

254

1.27

0.70

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

123

893

1.14

0.70

1.1

—

(3044007) Cell count panel - Peritoneal fluid

120

0.62

0.70

1.3

2.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.47

0.69

1.1

0.29

15.06

u/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

135

988

1.13

0.69

1.7

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

215

1616

1.10

0.68

3.4

2.8

0.85

0.82

nmol/l

0.33

188

1373

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.65

0.68

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8934

74361

0.98

0.68

4.1

3.8

36.88

37.12

mmol/mol

1.29

8550

70427

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2499

21123

0.97

0.67

2.3

2.0

—

(3000012) Reticulocyte production index

626

1.16

0.67

2.2

2.1

—

(40768797) Stomach Pathology biopsy report

1226

9751

1.04

0.67

1.2

—

(3033799) Differential panel - Peritoneal fluid

129

0.64

0.67

3.0

2.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.79

0.66

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.79

0.66

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

134

984

1.12

0.65

3.8

4.3

49.73

98.95

u/ml

1.26

321

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.55

0.65

1.0

1.1

4.06

5.21

u/l

—

(3024263) Appearance of Synovial fluid

287

1.24

0.65

1.6

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

698

1.15

0.64

1.2

1.4

6.94

6.38

ug/l

0.09

613

(3009508) Creatinine [Moles/volume] in Urine

2773

22377

1.03

0.64

3.5

3.4

8.71

8.62

mmol/l

0.35

2537

19980

(3034426) Prothrombin time (PT)

415

1.19

0.64

1.3

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

563

4401

1.06

0.64

2.0

2.3

28.53

34.99

u/ml

1.06

543

4246

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

217

1638

1.09

0.64

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.62

0.64

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

910

7823

0.96

0.63

1.5

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

104

975

0.88

0.63

1.3

1.5

386.86

508.83

pmol/l

0.54

867

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

715

1.14

0.63

2.7

2.9

92.98

141.10

au/ml

0.62

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.44

0.63

1.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

518

4043

1.06

0.63

1.4

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

519

4523

0.94

0.62

1.7

1.5

—

(3023419) Bacteria identified in Sputum by Culture

654

1.15

0.62

3.4

3.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

166

1239

1.11

0.62

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

654

5140

1.05

0.62

1.1

1.27

17.67

u/ml

1.40

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

107

779

1.13

0.61

3.3

3.5

8.28

8.54

mg/l

0.15

627

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

609

1.15

0.61

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.61

0.0

1.3

—

26.79

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

538

4210

1.06

0.60

2.2

2.4

4.92

5.25

umol/l

0.29

403

3125

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

874

0.88

0.60

1.7

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

130

960

1.12

0.60

2.0

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

138

1023

1.11

0.59

1.7

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

385

0.81

0.59

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

234

1781

1.09

0.59

1.1

116.93

115.46

0.35

220

1614

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

314

2418

1.07

0.59

1.7

1.8

176.16

186.01

pmol/l

0.78

300

2315

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.59

1.0

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

444

3460

1.06

0.58

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2194

17680

1.03

0.58

2.7

2.3

3247.80

2672.54

umol/l

0.37

2024

16117

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.57

1.1

—

(3024928) Oxygen saturation in Venous blood

158

1434

0.91

0.57

5.4

3.4

—

(3036489) Thrombin time

485

3794

1.06

0.56

2.8

2.4

21.06

20.86

0.29

412

3168

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

152

1.30

0.56

1.1

1.0

23.33

24.06

u/ml

0.03

124

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

364

2825

1.06

0.55

2.1

4.00

21.91

iu/l

0.50

149

1122

(3004616) Nuclear Ab [Presence] in Serum

134

997

1.11

0.55

1.4

1.3

—

(3000991) Gas panel - Venous blood

722

5710

1.05

0.55

10.3

8.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

182

1.27

0.54

1.4

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

160

1.29

0.54

1.2

1.6

106.73

54.85

ng/l

0.22

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

279

1.21

0.54

2.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

531

1.15

0.54

1.4

1.7

1.49

3.09

nmol/l

1.61

429

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.49

0.54

1.0

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

174

1315

1.09

0.53

1.8

1.7

12543.89

12879.67

e6/l

0.04

129

966

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.53

0.52

1.0

1.5

—

(1002224) Polysomnography panel

510

4417

0.95

0.52

1.1

—

(3017732) Neutrophils [#/volume] in Blood

817

6489

1.04

0.52

2.5

2.2

4.94

4.64

e9/l

0.22

691

5631

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

112

829

1.12

0.52

1.1

289.12

285.21

mg/l

0.18

104

758

(3020682) Albumin/Creatinine [Ratio] in Urine

1938

15619

1.03

0.52

4.6

4.2

13.39

12.14

mg/mmol

0.39

1404

10787

(1617658) Protocol used for examination of sentinel lymph nodes

396

0.83

0.52

1.1

—

(3001556) Androgen free Index in Serum or Plasma

334

1.19

0.51

1.1

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

403

1.17

0.51

1.7

1.4

13.74

13.84

pmol/l

0.06

342

(1616796) Gas panel - Central venous blood

214

1636

1.08

0.51

3.1

3.3

—

(3000492) Spirometry study

1279

10249

1.03

0.51

1.4

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

111

823

1.11

0.50

1.2

1.3

217.14

243.25

titre

0.12

154

(3051611) Lipemic interference index of Serum or Plasma

668

0.88

0.50

4.8

2.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

136

1232

0.91

0.50

1.4

1.9

39.63

39.03

g/l

0.57

123

1134

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

305

1.19

0.50

1.2

1.1

91.82

72.11

0.43

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

119

1.32

0.49

2.1

3.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

459

1.15

0.49

1.8

2.1

1210.61

138.80

ug/l

0.58

431

(3035933) Granulocytes/100 leukocytes in Blood

455

0.85

0.48

1.3

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1538

1.08

0.48

2.0

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1538

1.08

0.48

2.0

1.9

3.64

3.62

g/l

0.08

188

1440

(3020191) Ethanol [Moles/volume] in Serum or Plasma

118

1074

0.91

0.48

1.4

1.6

1.35

1.38

promille

0.08

824

(21494755) Public health laboratory ask at order entry panel

1919

16186

0.97

0.48

1.2

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

105

1.34

0.48

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

105

1.34

0.48

1.1

1.0

0.21

18.31

u/ml

—

(1761868) Lipid panel - Serum or Plasma

4512

36751

1.02

0.47

2.3

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1539

1.08

0.47

2.0

1.9

7.06

7.16

g/l

0.35

188

1440

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

187

1428

1.08

0.47

4.0

4.4

0.29

0.34

u/ml

1.63

102

762

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

269

2364

0.94

0.47

1.6

1.5

723.72

2713.58

e6/l

0.63

227

1912

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

202

0.78

0.47

3.6

2.4

1.55

1.59

mmol/l

0.02

151

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.46

1.5

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

663

5264

1.04

0.45

1.4

1.5

4.18

3.99

mg/l

0.13

445

3523

(3001186) Copper [Moles/volume] in Serum or Plasma

278

1.19

0.45

1.1

1.5

17.70

16.31

umol/l

0.96

249

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

225

1.21

0.45

1.2

1.5

8.71

9.02

ug/l

0.17

225

(3028308) Erythrocytes [#/volume] in Pleural fluid

318

0.83

0.45

1.4

1.5

159903.81

68073.29

e6/l

0.31

190

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

502

1.13

0.44

1.2

1.1

1.24

3.94

nmol/l

0.75

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

270

2363

0.94

0.43

1.6

1.5

15.44

22.51

e6/l

0.53

216

1819

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

100

746

1.11

0.43

2.5

1.6

—

(40768441) Liver Pathology biopsy report

597

1.12

0.43

2.1

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

581

0.88

0.43

1.7

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

144

1.26

0.43

1.0

0.60

2.49

u/ml

0.94

117

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

446

3517

1.05

0.43

3.0

2.7

134.04

120.69

ng/l

0.33

408

3023

(3011985) Renin [Units/volume] in Plasma

118

1065

0.91

0.42

2.0

1.9

83.14

57.32

mu/l

0.52

108

972

(3013293) Extractable nuclear Ab [Presence] in Serum

137

1.27

0.42

1.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.40

0.42

1.1

1.0

18.79

25.63

u/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

152

1.25

0.42

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.1

—

5.17

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

513

1.13

0.41

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

304

1.17

0.41

1.3

1.1

112.20

79.73

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

345

2707

1.05

0.41

1.4

82.05

95.63

titre

0.41

270

(40765089) Chromosome analysis panel - Blood by G-banded

114

1028

0.91

0.41

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

639

1.11

0.41

3.7

3.0

—

0.69

—

(3036071) Salmonella sp Ab [Titer] in Serum

473

0.87

0.40

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

119

1070

0.92

0.40

1.4

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

671

1.11

0.40

1.2

5.27

18.59

u/ml

1.06

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

183

1.22

0.40

1.0

0.09

1.50

u/ml

1.50

116

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

358

2815

1.05

0.40

5.8

3.7

24.27

24.39

mmol/l

0.36

347

2683

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.32

0.40

1.0

1.2

—

(3044941) Cell count panel - Synovial fluid

121

917

1.09

0.39

1.6

1.4

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.39

0.0

1.4

—

192.19

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

163

1251

1.08

0.39

1.1

1.48

1.44

g/l

0.59

149

1140

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

489

3875

1.04

0.39

1.5

—

(3020650) Glucose [Presence] in Urine

329

1.15

0.39

1.5

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

256

2234

0.94

0.39

1.7

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

458

3938

0.96

0.39

3.7

3.9

3.81

25.10

ug/l

1.55

336

2839

(3006576) Bicarbonate [Moles/volume] in Blood

214

0.81

0.39

4.8

6.3

22.58

24.33

mmol/l

1.68

204

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

222

1.19

0.38

1.0

0.01

0.02

u/ml

1.24

126

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

514

0.88

0.38

1.7

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.36

0.38

3.2

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

478

3790

1.04

0.38

2.6

2.2

66.82

67.42

g/l

1.10

459

3547

(3030313) Adrenal Ab [Titer] in Serum

213

0.81

0.37

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

255

1992

1.06

0.37

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.69

0.37

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.40

0.37

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

691

1.10

0.37

2.3

2.7

3.55

11.70

nmol/l

0.50

666

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

194

1504

1.07

0.36

3.5

3.7

111.50

1177.15

u/ml

0.94

175

1295

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

262

1.17

0.36

1.3

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

148

1.23

0.36

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.29

0.35

2.8

1.3

61.43

55.23

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

155

1194

1.07

0.35

1.1

1.90

5.28

u/ml

0.80

345

(40763590) HLA-DQ beta [Type]

1.41

0.35

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.41

0.35

1.0

—

(40768806) Pleura Pathology biopsy report

291

0.85

0.35

1.4

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.30

0.34

1.1

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

129

0.77

0.34

1.1

1.2

42.86

39.40

g/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

155

1196

1.07

0.34

2.0

5.44

5.21

mmol/24h

0.38

146

1090

(3010937) Rubella virus Ab [Presence] in Serum

149

1.22

0.34

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.34

0.34

1.2

1.0

26.17

62.00

u/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

491

0.89

0.33

1.4

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3738

30498

1.02

0.33

6.9

5.4

1.22

1.21

mmol/l

0.44

3455

28112

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

790

6341

1.03

0.33

2.9

2.6

0.23

g/l

0.23

747

5925

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

257

1.16

0.33

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

150

1.21

0.32

1.7

1.4

40.00

38.92

0.05

103

(44816559) Phosphatidylethanol [Mass/volume] in Blood

361

2860

1.04

0.32

1.3

1.4

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

250

1.16

0.32

1.0

1.07

1.58

u/ml

0.23

198

(3023199) Leukocytes [#/volume] in Pleural fluid

358

0.88

0.31

1.4

1.5

8653.86

2808.92

e6/l

0.67

250

(3024869) Neuronal Ab [Presence] in Serum

1.29

0.31

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

764

0.92

0.31

1.5

1.9

23.47

25.75

mg/l

0.13

219

(3013762) Body weight Measured

1.34

0.31

1.0

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

136

0.79

0.31

5.6

9.0

—

(3008607) Semen analysis panel

220

1.16

0.31

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

174

1.19

0.31

1.3

1.1

—

(3042631) Mycobacterium sp identified in Specimen

526

1.10

0.30

2.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

748

6013

1.03

0.30

7.0

7.9

5.02

5.01

kpa

0.17

720

5744

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

244

1.15

0.30

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

180

1569

0.95

0.30

5.7

5.5

400.79

373.69

umol/l

1.69

161

1380

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

962

7761

1.02

0.29

2.9

3.0

32.61

31.75

1.73

783

5904

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

260

1.14

0.29

1.1

—

(36304419) Bacteria [Presence] in Urine

2731

22258

1.02

0.29

3.0

2.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

456

1.10

0.29

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

364

0.88

0.29

1.2

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.23

0.29

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.29

0.28

1.1

1.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

747

6012

1.03

0.28

7.0

7.9

13.62

13.66

kpa

0.07

720

5744

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

172

1496

0.95

0.27

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1079

9078

0.98

0.27

3.7

2.7

5.87

6.56

umol/l

0.95

915

7645

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

657

1.08

0.27

2.4

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

141

1097

1.06

0.27

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.22

0.27

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2386

19443

1.01

0.27

1.5

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

146

1.19

0.27

1.1

1.2

15.92

27.89

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

146

1.19

0.27

1.1

1.2

22.04

37.04

u/ml

—

(3022670) pH of Venous cord blood

1.31

0.26

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

172

1494

0.95

0.26

1.3

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.70

0.26

3.0

4.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.69

0.26

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

265

0.87

0.26

1.4

1.3

—

709.00

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

168

0.83

0.26

1.0

1.1

—

(3035880) pH of Pleural fluid

150

0.82

0.25

1.1

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

548

1.08

0.25

1.7

1.6

35.49

39.33

0.41

358

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

342

2726

1.04

0.25

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

143

1246

0.95

0.25

1.9

0.00

0.01

g/l

1.63

137

1169

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

100

772

1.07

0.25

1.1

1.00

1.02

u/l

0.20

326

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

133

1037

1.06

0.24

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.25

0.24

2.0

2.1

1.00

0.91

u/field

0.09

(3002256) Pathology report gross observation

1173

9842

0.98

0.24

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

179

1.15

0.24

1.1

1.0

—

(40758558) Short blood count panel - Blood

2697

22021

1.01

0.24

6.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.33

0.23

1.0

1.8

—

(3003157) Bacteria [#/volume] in Mother's milk

1.26

0.23

5.6

6.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

164

1.16

0.23

1.6

1.2

—

(3032641) Amino acids panel - Urine

1.29

0.23

1.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

337

1.10

0.22

1.1

—

(3006462) Nitrate [Presence] in Urine

456

1.09

0.22

1.6

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

112

872

1.06

0.22

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

322

0.90

0.22

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

282

1.11

0.22

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

157

1.16

0.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

157

1.16

0.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

157

1.16

0.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

157

1.16

0.22

1.1

—

(40768795) Lymph node Pathology biopsy report

655

0.93

0.22

1.4

1.2

—

(40760409) HLA-A [Type] by High resolution

1.21

0.22

1.0

—

(40760410) HLA-B [Type] by High resolution

1.21

0.22

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

128

1002

1.05

0.22

3.0

3.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.9

—

8.33

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

6.7

—

(3013862) HLA-DP [Type]

1.18

0.21

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

260

0.89

0.21

2.0

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

119

1.18

0.21

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

554

1.07

0.21

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

292

2333

1.03

0.20

1.5

1.4

3.51

3.56

mmol/l

0.40

276

2200

(3002619) Bacteria identified in Specimen by Culture

190

0.87

0.20

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.20

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

319

0.90

0.20

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.25

0.20

1.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.21

0.19

1.0

1.8

—

9.33

—

(3004451) EKG impression Narrative

189

0.87

0.19

1.1

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

412

1.08

0.19

1.4

1.5

2.76

3.48

u/field

0.33

301

(3036048) Francisella tularensis Ab [Titer] in Serum

262

1.10

0.18

1.2

1.1

—

163.33

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

188

0.88

0.18

2.6

2.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8528

70596

0.99

0.18

3.0

2.8

34.94

34.59

u/l

0.14

8188

67628

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

102

799

1.05

0.18

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

351

2821

1.03

0.18

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

153

1212

1.04

0.18

1.1

1.74

3.16

u/ml

0.47

447

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2113

17598

0.99

0.18

1.8

1.36

0.10

1947

15986

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

176

1.13

0.17

1.1

1.0

—

(3018418) pH of Serum or Plasma

2418

19778

1.01

0.17

5.1

3.7

7.39

7.40

2.10

461

3903

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10720

88648

0.99

0.17

3.3

2.79

2.83

mmol/l

4.55

10286

84166

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

106

1.17

0.17

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1802

15016

0.99

0.17

3.8

3.6

545.16

364.68

mg/l

0.79

1294

10372

(40768793) Breast Pathology biopsy report

199

1588

1.03

0.17

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

195

0.89

0.16

1.6

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

1475

1.04

0.16

2.0

1.9

2.81

2.89

g/l

0.59

172

1376

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

696

5836

0.98

0.16

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

679

0.95

0.16

2.0

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

731

1.05

0.15

1.7

1.9

—

(3051339) Copper [Moles/volume] in Blood

0.77

0.15

1.2

1.5

15.27

15.87

umol/l

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.76

0.15

1.7

1.3

1.32

1.47

mg/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

194

0.89

0.15

1.3

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.75

0.15

1.3

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

127

1007

1.04

0.15

1.2

1.3

194.50

196.45

pmol/l

0.05

127

1007

(3020491) Glucose [Moles/volume] in Blood

101

797

1.05

0.15

1.4

1.7

5.38

5.86

mmol/l

2.19

668

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

176

0.89

0.15

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

210

0.90

0.14

3.6

3.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

645

1.05

0.14

1.4

1.38

1.39

nmol/l

0.06

587

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

549

0.95

0.14

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

116

1.14

0.14

1.2

1.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

671

5617

0.98

0.14

7.5

7.1

1.31

1.35

mmol/l

0.70

655

5487

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

484

1.06

0.14

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

275

2216

1.02

0.13

1.1

3.70

2.54

u/ml

0.69

146

1162

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

209

0.91

0.13

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

262

2111

1.02

0.13

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

260

0.92

0.13

1.9

2.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

172

1.10

0.13

1.3

1.8

2.81

7.92

nmol/l

1.03

161

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

135

1077

1.03

0.13

1.5

1.3

0.13

0.32

nmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

252

1.08

0.13

1.1

—

(3012441) Differential panel - Pleural fluid

302

0.93

0.13

1.3

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

169

1355

1.03

0.12

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

128

1022

1.03

0.12

3.4

2.9

6.96

1.86

ratio

0.56

109

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

835

6968

0.99

0.12

2.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

204

1725

0.98

0.12

1.3

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

197

1666

0.98

0.11

1.5

2.1

—

(3017569) Oxygen content in Arterial blood

207

0.92

0.11

2.1

2.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1323

11006

0.99

0.11

2.4

2.5

2.40

2.41

mmol/l

1.86

1168

9520

(3010015) Selenium [Moles/volume] in Serum or Plasma

118

1.12

0.11

2.2

1.24

1.23

umol/l

0.03

107

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

134

1.11

0.11

1.1

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10196

83979

1.01

0.11

3.0

2.9

1.20

1.22

mmol/l

2.95

9791

79849

(3040151) Glucose [Moles/volume] in Capillary blood

102

871

0.97

0.11

4.2

6.61

7.01

mmol/l

0.49

703

(3034860) Kappa light chains.free [Mass/volume] in Serum

131

1049

1.03

0.11

3.6

2.9

45.96

54.11

mg/l

0.38

114

837

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

359

1.06

0.11

1.1

280.78

141.70

ng/l

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

787

0.96

0.11

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

448

1.05

0.11

3.5

5.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

165

1327

1.03

0.10

1.1

—

22.31

—

(3049717) Cytology report of Urine Cyto stain

153

1296

0.97

0.10

2.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.16

0.10

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

103

1.12

0.10

1.3

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

143

1211

0.97

0.10

1.1

1.2

30.81

40.26

mg/l

3.93

119

1008

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

183

1.08

0.10

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

167

1.09

0.10

3.9

4.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

131

1052

1.03

0.09

3.6

2.9

39.68

37.49

mg/l

0.10

115

843

(3015076) Soybean IgE Ab [Units/volume] in Serum

138

1110

1.03

0.09

1.1

1.0

0.51

1.35

u/ml

0.93

318

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

457

0.96

0.09

2.2

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

163

1375

0.98

0.09

4.0

2.8

32.21

34.12

umol/l

0.59

152

1291

(40761536) Microorganisms panel - Urine sediment

1127

9367

0.99

0.09

3.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

297

1.06

0.09

2.2

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

793

1.03

0.08

4.3

2.9

—

(3011048) Pyruvate [Moles/volume] in Blood

104

1.11

0.08

1.0

1.4

76.93

84.07

umol/l

0.34

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

187

0.93

0.08

1.0

27.77

41.48

ng/l

1.92

121

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.11

0.08

1.1

1.4

542.53

547.54

nmol/l

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.07

0.08

1.0

27.14

12.12

u/ml

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

781

0.97

0.08

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.05

0.08

1.0

1.1

—

(4035726) Immunohistochemistry procedure

615

5027

1.01

0.08

1.5

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

177

1433

1.02

0.07

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

100

847

0.97

0.07

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.80

0.07

1.0

1.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

250

1.06

0.07

1.0

1.1

4.04

1.38

u/ml

0.34

193

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

145

1.08

0.07

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

226

1.06

0.07

1.2

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

299

1.05

0.07

2.2

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

105

1.10

0.07

1.1

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.82

0.07

1.7

2.1

—

(3000285) Sodium [Moles/volume] in Blood

0.82

0.07

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

723

1.03

0.07

1.6

1.7

48.63

51.02

0.21

481

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

134

1083

1.02

0.07

1.5

1.3

0.48

0.50

nmol/l

0.18

129

1046

(3050794) Legionella sp Ab [Presence] in Serum

1.03

0.07

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

332

1.04

0.07

2.5

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

179

1502

0.98

0.07

2.2

2.3

17.80

17.45

0.52

737

(3008898) HLA-B27 [Presence]

651

5414

0.99

0.07

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.85

0.06

1.1

1.65

1.63

umol/24h

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

185

0.94

0.06

1.0

958.63

822.42

ng/l

0.59

124

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

114

961

0.98

0.06

1.6

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.89

0.06

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.86

0.06

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

511

0.97

0.06

2.5

2.8

58.00

51.42

umol/l

0.95

469

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.85

0.06

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

130

1.08

0.06

4.2

8.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

236

1973

0.99

0.06

1.6

1.7

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

114

1.09

0.06

20.9

11.1

0.35

0.38

umol/l

0.14

104

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10694

88153

1.00

0.06

3.2

3.1

4.63

4.67

mmol/l

4.24

10295

84201

(3017509) Phencyclidine [Presence] in Urine

301

0.96

0.05

2.0

2.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

138

1158

0.98

0.05

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

744

6176

0.99

0.05

1.3

43.04

44.95

au/ml

0.06

238

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

159

1332

0.98

0.05

2.1

2.0

0.60

0.57

g/l

0.05

148

1215

(3047189) Immunofixation for 24 hour Urine

147

1.07

0.05

1.2

1.6

—

(3015183) Erythrocyte sedimentation rate

735

1.02

0.05

1.6

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

320

2665

0.99

0.05

1.6

1.4

450.23

451.91

mg/l

0.02

304

2545

(3035947) Staphylolysin Ab [Units/volume] in Serum

400

1.03

0.05

1.1

4.56

4.25

iu/ml

—

(3004588) Protein electrophoresis panel - Serum or Plasma

338

2764

1.01

0.05

2.1

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1433

1.01

0.05

1.6

2.0

10.06

10.36

g/l

0.47

163

1332

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.10

0.04

1.8

1.4

303.10

306.33

umol/24h

—

(40768443) Skin Pathology biopsy report

373

3100

0.99

0.04

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

623

0.98

0.04

1.1

88.30

92.33

0.56

499

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

369

3023

1.01

0.04

8.8

10.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

143

1195

0.99

0.04

5.5

3.3

68.40

64.87

1.26

143

1190

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

120

976

1.01

0.04

1.6

1.7

—

(4146454) Self-monitoring of blood glucose

451

1.02

0.04

3.1

2.8

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

108

1.07

0.03

1.1

7.26

7.14

kpa

0.11

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

348

0.97

0.03

1.5

1.6

0.20

0.22

nmol/l

0.20

265

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

572

0.98

0.03

1.5

1.2

2.60

23.43

u/ml

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

105

878

0.99

0.03

1.2

1.1

1.03

1.06

ratio

1.69

325

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

131

0.94

0.03

1.6

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

979

1.01

0.02

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

486

1.02

0.02

7.2

7.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

396

3283

1.00

0.02

1.4

1.3

—

(3006598) pH of Arterial cord blood

109

1.06

0.02

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

101

1.06

0.02

3.4

3.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

503

0.98

0.02

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

594

0.99

0.02

1.4

1.2

41.78

45.00

u/ml

—

(3036180) Methadone [Presence] in Urine

163

1335

1.01

0.02

2.0

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

174

1426

1.01

0.02

1.5

1.4

—

(3007463) Buprenorphine [Presence] in Urine

126

1.05

0.01

5.7

6.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

121

990

1.01

0.01

1.1

—

(3014271) Vancomycin [Susceptibility]

159

1.04

0.01

2.9

2.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

805

6630

1.00

0.01

2.3

17.09

19.90

au/ml

0.56

622

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

195

1601

1.00

0.01

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

464

1.01

0.01

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

670

1.01

0.01

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

268

2219

1.00

0.01

1.5

1.4

53.96

84.20

pmol/l

2.36

258

2146

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

187

0.97

0.01

1.0

217.85

285.94

ng/l

1.38

127

(3002621) Streptococcal DNAse B [Units/volume] in Serum

129

0.96

0.01

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10611

87534

1.00

0.00

3.2

3.1

1.45

1.44

mmol/l

2.08

10218

83449

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

938

0.99

0.00

1.0

—

(3019174) dRVVT (LA screen)

127

1.04

0.00

1.1

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

591

0.99

0.00

1.4

1.2

38.67

41.41

u/ml

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

292

1.02

0.00

1.6

1.5

3.13

5.75

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

178

0.97

0.00

1.2

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

416

1.01

0.00

1.4

122.65

96.18

nmol/24h

0.34

416

(3051651) Icteric interference index of Serum or Plasma

475

0.99

0.00

5.6

3.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.03

0.00

1.2

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

269

1.01

0.00

1.4

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

129

1.02

0.00

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

280

1.00

0.00

1.4

17.14

19.72

u/ml

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

448

0.99

0.00

6.0

6.5

4349.29

6933.58

u/ml

—

103

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

565

0.99

0.00

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

763

1.01

0.00

3.5

3.6

107.88

596.15

u/ml

0.81

704

(3005082) Progesterone [Moles/volume] in Serum or Plasma

231

1910

1.00

0.00

1.5

1.4

31.18

32.54

nmol/l

0.30

213

1783

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

149

1229

1.00

0.00

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

408

0.99

0.00

1.2

1.4

128.99

133.26

nmol/l

0.26

408

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

142

1174

1.00

0.00

1.1

200.09

230.10

mg/l

1.59

127

1033

(3003434) Protein [Mass/volume] in Pleural fluid

364

1.00

0.00

1.2

1.5

38.06

35.22

g/l

0.68

329

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

201

0.99

0.00

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

140

1159

1.00

0.00

2.0

1.7

24.29

30.19

iu/ml

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

159

1313

1.00

0.00

1.1

—

41.90

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

109

898

1.00

0.00

2.0

1.5

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

103

1.04

0.00

1.1

4.25

4.28

kpa

0.01

(3027923) C peptide [Moles/volume] in Serum or Plasma

404

1.00

0.00

1.7

2.1

1.09

1.38

nmol/l

1.07

332

(3026692) Albumin [Mass/volume] in Peritoneal fluid

115

1.00

0.00

1.3

1.4

12.12

13.59

g/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

151

0.98

0.00

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

151

0.98

0.00

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

356

1.00

0.00

1.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.0

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

2.06

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.1

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40763527) Lymphocytes.vacuolated [Presence] in Blood by Light microscopy

0.00

0.0

1.2

—

0.00

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.88

-0.00

1.0

1.1

4.33

15.13

u/l

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.95

-0.00

1.1

—

18.60

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.97

-0.00

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.94

-0.00

1.2

1.1

7.62

0.05

mg/l

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.93

-0.00

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.92

-0.00

1.2

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_EMBIMPACT_TEETH and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_EMBIMPACT_TEETH	1.174 [0.95, 1.45]	0.135
Birth year	0.997 [0.99, 1.01]	0.457

During the follow-up period (1.1.1998 — 31.12.2019), 637 out of 66317 females with K11_EMBIMPACT_TEETH died.

Males

Parameter	HR [95% CI]	p-value
K11_EMBIMPACT_TEETH	1.373 [1.16, 1.63]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 1198 out of 50315 males with K11_EMBIMPACT_TEETH died.

Mortality risk

Mortality risk for people of age

years, who have K11_EMBIMPACT_TEETH.

N-year risk	Females	Males
1	0.091%	0.231%
5	0.72%	1.629%
10	1.873%	3.84%
15	3.543%	7.403%
20	6.222%	12.612%

Relationships between endpoints

↥

Index endpoint: K11_EMBIMPACT_TEETH – Embedded and impacted teeth

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Embedded and impacted teeth

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints